RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Respiratory Tract Infections
Accession: DOID:9008680
browse the term
Definition: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
Synonyms: exact_synonym: Respiratory Infection, Upper; Respiratory Infections; Respiratory Tract Infection; Upper Respiratory Infections; Upper Respiratory Tract Infections
primary_id: MESH:D012141 ; RDO:0000329
G
BDNF
brain derived neurotrophic factor
IEP
protein:decreased expression:platelet, serum
RGD
PMID:17317133
RGD:4891069
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:19039768
RGD:4892119
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
FBLN5
fibulin 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12189163
NCBI chr14:91,869,411...91,947,694
Ensembl chr14:91,869,411...91,947,987
G
HLA-G
major histocompatibility complex, class I, G
IAGP
RGD
PMID:19775370
RGD:5144114
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
G
IL13
interleukin 13
IEP
Severe Acute Respiratory Syndrome
RGD
PMID:14633438
RGD:4145665
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL16
interleukin 16
IEP
protein:increased expression:serum
RGD
PMID:14633438
RGD:4145665
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
G
IL4
interleukin 4
IEP
associated with Asthma
RGD
PMID:20573437
RGD:5128554
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6R
interleukin 6 receptor
IAGP
DNA:polymorphisms:promoter, exon:-183G>A (human)
RGD
PMID:20951753
RGD:5128631
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
IRF1
interferon regulatory factor 1
ISO
RGD
PMID:10497103
RGD:5128721
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
IRF3
interferon regulatory factor 3
ISO
RGD
PMID:17027894
RGD:5128795
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
G
LEPR
leptin receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17229951
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
MBL2
mannose binding lectin 2
susceptibility
IEP IAGP
protein:decreased secretion:serum (human) DNA:SNP:exon:p.G54D(rs1800450)(human) DNA:polymorphisms:5' utr, exon:multiple (human)
RGD
PMID:19169708 PMID:15249448 PMID:19767106
RGD:4889453 , RGD:8693755 , RGD:4889439
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MX1
MX dynamin like GTPase 1
IEP
protein:increased expression:blood (human)
RGD
PMID:25542463
RGD:126777677
NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
G
RPGR
retinitis pigmentosa GTPase regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12920075
NCBI chr X:38,269,163...38,327,509
Ensembl chr X:38,269,163...38,327,544
G
TNF
tumor necrosis factor
IEP
Severe Acute Respiratory Syndrome; protein:increased expression:serum
RGD
PMID:14633438
RGD:4145665
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
CCL17
C-C motif chemokine ligand 17
IEP
associated with Cystic Fibrosis
RGD
PMID:17898016
RGD:4145612
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:15951834
RGD:5688155
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:10946288
RGD:8661731
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CFTR
CF transmembrane conductance regulator
IAGP
DNA:mutations: :
RGD
PMID:11243954
RGD:4140482
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP
associated with cystic fibrosis; DNA:polymorphisms: :DQB1*06:02, DQB1*02:01(human)
RGD
PMID:23278646
RGD:36049760
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility
IAGP
associated with cystic fibrosis; DNA:polymorphisms: :
RGD
PMID:23278646
RGD:36049760
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
ICAM1
intercellular adhesion molecule 1
ISO
RGD
PMID:7743671
RGD:8547590
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IL1A
interleukin 1 alpha
ISO
RGD
PMID:8699818
RGD:7794730
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
MBL2
mannose binding lectin 2
susceptibility
IAGP
Chronic Necrotizing Pulmonary Aspergillosis; DNA:missense mutation:exon:p.R52C (human) DNA:SNP:intron:1011G>A(human)
RGD
PMID:11474427 PMID:16487239
RGD:4889577 , RGD:8693711
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
TLR9
toll like receptor 9
susceptibility
ISO IAGP
DNA:SNP:promoter:g.-1237T>C (rs5743836) (human)
RGD
PMID:18936185 PMID:18275280
RGD:5130858 , RGD:5130863
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TNF
tumor necrosis factor
ISO
RGD
PMID:8699818
RGD:7794730
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
IAGP
DNA:snps:5' utr, exon:g.-609G>T rs4149570, g.36A>G rs767455 (human)
RGD
PMID:20646338
RGD:5131174
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
ABCB1
ATP binding cassette subfamily B member 1
severity
IAGP
DNA:snp:exon:c.1236C>T (human)
RGD
PMID:24040855
RGD:8657076
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ACE
angiotensin I converting enzyme
no_association
IAGP
DNA:deletion:intron:IVS16+1464-1751del (human)
RGD
PMID:15112973
RGD:8142345
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
BCL2
BCL2 apoptosis regulator
ISO
mRNA, protein:increased expression:nasal mucosa (rat)
RGD
PMID:15362690
RGD:11522724
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
CAT
catalase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29028686
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL11
C-C motif chemokine ligand 11
treatment
ISO
RGD
PMID:23089405
RGD:7248414
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL26
C-C motif chemokine ligand 26
IEP
protein:increased expression:oronasal secretion (human)
RGD
PMID:23883806
RGD:7364793
NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896
G
CD40
CD40 molecule
IEP
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD40LG
CD40 ligand
IEP
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CLDN3
claudin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr 7:73,768,997...73,770,270
Ensembl chr 7:73,768,997...73,770,270
G
CLDN7
claudin 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr17:7,259,903...7,263,213
Ensembl chr17:7,259,903...7,263,983
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
treatment
ISO
RGD
PMID:10436391
RGD:11344920
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
F2
coagulation factor II, thrombin
IEP
protein:increased expression:nasal mucus
RGD
PMID:21711961
RGD:5147783
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
FCGR3A
Fc gamma receptor IIIa
susceptibility
IAGP
DNA:polymorphism:exon:p.F158V(rs396991)(human)
RGD
PMID:18199088
RGD:5508449
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869
G
GRIA2
glutamate ionotropic receptor AMPA type subunit 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chr 4:157,220,120...157,366,075
Ensembl chr 4:157,204,182...157,387,146
G
HLA-G
major histocompatibility complex, class I, G
IEP
RGD
PMID:20487636
RGD:5144132
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
G
HRH1
histamine receptor H1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23333628
NCBI chr 3:11,137,238...11,263,557
Ensembl chr 3:11,137,093...11,263,557
G
IFNG
interferon gamma
treatment
IEP EXP ISO
associated with Asthma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29871060 PMID:12787306 PMID:18510219
RGD:7829803 , RGD:10755770
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL10
interleukin 10
treatment
IEP ISO
RGD
PMID:23883806 PMID:23253209
RGD:7364793 , RGD:7364818
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL13
interleukin 13
susceptibility no_association
IAGP EXP
DNA:SNP:promoter:-1512A>C (rs1881457) (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:exon:c. 2044G>A (human) DNA:missense mutation:cds:p.R130Q (rs20541) (human) DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human)
CTD OMIM RGD
PMID:23996716 PMID:17091279 PMID:22852128 PMID:12928861
RGD:8549501 , RGD:4152796 , RGD:8549518 , RGD:8549516
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL13RA2
interleukin 13 receptor subunit alpha 2
IEP
protein:increased expression:serum
RGD
PMID:21462799
RGD:8549521
NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977
G
IL17A
interleukin 17A
susceptibility
IAGP IEP
DNA:snp:promoter:c.-444A>G (human) mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:22507625 PMID:21535180
RGD:9068429 , RGD:5147409
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
severity no_association
IAGP
DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNP:promoter:-140C>G (rs360721) (human)
RGD
PMID:22840759 PMID:22840759
RGD:8655914 , RGD:8655914
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1B
interleukin 1 beta
IEP
protein:increased expression:nasal mucus
RGD
PMID:7750009
RGD:7401199
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL2
interleukin 2
ISO
RGD
PMID:12592663
RGD:8662963
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL4
interleukin 4
treatment
IEP ISO
RGD
PMID:9893928 PMID:24620662 PMID:8908280 PMID:14653048
RGD:7829796 , RGD:11522769 , RGD:7829827 , RGD:7829802
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL5
interleukin 5
treatment
ISO
RGD
PMID:23934070 PMID:24620662
RGD:11354976 , RGD:11522769
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
ITGB2
integrin subunit beta 2
treatment
ISO
RGD
PMID:12046991
RGD:9698435
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
G
MUC1
mucin 1, cell surface associated
severity
IEP ISO
mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:31425778 PMID:31425778 PMID:31425778
RGD:127345100 , RGD:127345100 , RGD:127345100
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:22972875
RGD:7364746
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
NOD2
nucleotide binding oligomerization domain containing 2
IEP
mRNA:increased expression:nasal mucosa (human)
RGD
PMID:23858718
RGD:8547523
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
OCLN
occludin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
G
PON1
paraoxonase 1
severity
IEP
protein:decreased activity:plasma (human)
RGD
PMID:23406590
RGD:8547583
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
PRKG1
protein kinase cGMP-dependent 1
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:24012634
RGD:7775060
NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423
G
PTGS2
prostaglandin-endoperoxide synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16979129
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
SCGB1A1
secretoglobin family 1A member 1
ISO
mRNA:decreased expression:nasal mucosa, lung
RGD
PMID:17882576
RGD:5144135
NCBI chr11:62,419,033...62,423,195
Ensembl chr11:62,405,103...62,423,195
G
SCGB3A2
secretoglobin family 3A member 2
susceptibility
IAGP
DNA:SNP: :rs7726552 (human)
RGD
PMID:21410962
RGD:5144225
NCBI chr 5:147,878,711...147,882,191
Ensembl chr 5:147,870,682...147,882,191
G
SERPINE1
serpin family E member 1
ISO
mRNA:increased expression:nasal mucosa (mouse)
RGD
PMID:21339035
RGD:8547809
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
TACR1
tachykinin receptor 1
ISO
mRNA:increased expression:nasal mucosa
RGD
PMID:12768696
RGD:5147835
NCBI chr 2:75,046,463...75,199,520
Ensembl chr 2:75,046,463...75,199,520
G
TGFB1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:31368266
RGD:14995445
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TLR2
toll like receptor 2
severity
IAGP IEP ISO
DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil: mRNA:decreased expression:nasal mucosa:
RGD
PMID:22402138 PMID:22555057 PMID:18381801 PMID:18219831
RGD:7800732 , RGD:8552993 , RGD:8552972 , RGD:7800742
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
severity treatment susceptibility no_association
IAGP IEP IDA
DNA:polymorphism:cds:p.D299G(human) protein:increased expression:nasal lavage,leukocyte, bone marrow: protein:decreased expression:nasal mucosa: DNA:SNP: :rs1927911(human) DNA:polymorphism: :4216G>C(human)
RGD
PMID:22402138 PMID:22555057 PMID:22577387 PMID:17069098 PMID:23639307 PMID:19763595 More...
RGD:7800732 , RGD:8552993 , RGD:7800740 , RGD:7800738 , RGD:7800736 , RGD:4145354
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR9
toll like receptor 9
IEP
protein:decreased expression:nasal mucosa:
RGD
PMID:22577387
RGD:7800740
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
treatment
IAGP
associated with Eosinophilic Esophagitis; DNA:polymorphisms::
RGD
PMID:26416193
RGD:11352743
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
IL3
interleukin 3
susceptibility
IAGP
DNA:SNP: :rs40401(human)
RGD
PMID:23953855
RGD:13506915
NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
G
AGER
advanced glycosylation end-product specific receptor
IAGP
DNA:SNP:promoter:-374T>A (human)
RGD
PMID:22114731
RGD:8695981
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
CCL19
C-C motif chemokine ligand 19
ISO
associated with Neutropenia;mRNA:increased expression:lung
RGD
PMID:19783686
RGD:5130908
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
G
CCR7
C-C motif chemokine receptor 7
ISO
associated with Neutropenia
RGD
PMID:19783686
RGD:5130908
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472
G
CD209
CD209 molecule
IMP
RGD
PMID:21381282
RGD:5131183
NCBI chr19:7,739,993...7,747,534
Ensembl chr19:7,739,993...7,747,564
G
CFTR
CF transmembrane conductance regulator
severity
ISO
RGD
PMID:22135344
RGD:35673332
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CLEC1A
C-type lectin domain family 1 member A
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Aspergillosis, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:29489751
NCBI chr12:10,069,554...10,098,985
Ensembl chr12:10,069,554...10,111,627
G
CLEC7A
C-type lectin domain containing 7A
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Aspergillosis, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868
NCBI chr12:10,116,777...10,130,304
Ensembl chr12:10,116,777...10,130,258
G
CRP
C-reactive protein
treatment
IEP
RGD
PMID:20879853
RGD:9495929
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
IL15
interleukin 15
IAGP
DNA:polymorphism (human)
RGD
PMID:16893395
RGD:4981337
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
MBL1P
mannose binding lectin 1, pseudogene
susceptibility
ISO
RGD
PMID:20064561
RGD:8694071
NCBI chr10:79,920,178...79,923,119
Ensembl chr10:79,920,327...79,923,032 Ensembl chr10:79,920,327...79,923,032
G
MBL2
mannose binding lectin 2
susceptibility
ISO
RGD
PMID:20064561
RGD:8694071
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
S100B
S100 calcium binding protein B
IAGP
DNA:SNP: :427C>T (human)
RGD
PMID:22114731
RGD:8695981
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
TLR1
toll like receptor 1
susceptibility
IAGP
DNA:SNPs: :p.R80T, p.N248S (human)
RGD
PMID:16461792
RGD:4889535
NCBI chr 4:38,787,569...38,805,644
Ensembl chr 4:38,790,677...38,856,817
G
TLR2
toll like receptor 2
ISO
mRNA:increased expression:lung
RGD
PMID:19781388
RGD:4145322
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR6
toll like receptor 6
susceptibility
IAGP
DNA:SNP: :p.S249P (human)
RGD
PMID:16461792
RGD:4889535
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
G
ACE
angiotensin I converting enzyme
IMP
associated with Cerebrovascular Accident
RGD
PMID:14990394
RGD:4140926
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
RGD
PMID:19515386
RGD:4891456
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL2
C-X-C motif chemokine ligand 2
ISO
RGD
PMID:19515386
RGD:4891456
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
EDN1
endothelin 1
ISO
protein:increased secretion:plasma (rat)
RGD
PMID:19262391
RGD:4145069
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
IL1A
interleukin 1 alpha
ISO
protein:increased expression:Bronchoalveolar Lavage Fluid
RGD
PMID:18042282
RGD:4142854
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
NOS2
nitric oxide synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15607125
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
TNF
tumor necrosis factor
ISO
protein:increased expression:Bronchoalveolar Lavage Fluid
RGD
PMID:18042282
RGD:4142854
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
CXCL8
C-X-C motif chemokine ligand 8
severity
IEP
protein:increased expression:nasal mucus (human)
RGD
PMID:24211414
RGD:40925940
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
MARCO
macrophage receptor with collagenous structure
disease_progression
ISO
association with Cryptococcal neoformans infection.
RGD
PMID:28298522
RGD:41412191
NCBI chr 2:118,942,194...118,994,660
Ensembl chr 2:118,942,194...118,994,660
G
ABCC1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
ISO
RGD
PMID:11238654
RGD:5128828
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ACE2
angiotensin converting enzyme 2
ISO
associated with Pseudomonas Infections;mRNA, protein:altered expression, altered activity:lung (mouse)
RGD
PMID:31645418
RGD:40818279
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
AGER
advanced glycosylation end-product specific receptor
severity
ISO
RGD
PMID:21629785
RGD:6767559
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
C3
complement C3
ISO
RGD
PMID:16014897
RGD:5129508
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C3AR1
complement C3a receptor 1
ISO
RGD
PMID:16461429
RGD:5129690
NCBI chr12:8,056,844...8,066,359
Ensembl chr12:8,056,844...8,066,359
G
C5
complement C5
ISO
RGD
PMID:17975174
RGD:5129707
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
CAT
catalase
ISO
RGD
PMID:19842849
RGD:5130748
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL19
C-C motif chemokine ligand 19
ISO
mRNA, protein:increased expression:lung
RGD
PMID:20176793
RGD:5130918
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
G
CCL2
C-C motif chemokine ligand 2
ISO
RGD
PMID:20042590
RGD:4891443
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL4
C-C motif chemokine ligand 4
ISO
RGD
PMID:20483921
RGD:5130905
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:20042590
RGD:4891443
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR7
C-C motif chemokine receptor 7
ISO
RGD
PMID:20176793
RGD:5130918
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472
G
CD14
CD14 molecule
ISO
RGD
PMID:16210672
RGD:4144197
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD40
CD40 molecule
ISO
RGD
PMID:20102413
RGD:5132268
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD80
CD80 molecule
ISO
RGD
PMID:20949109
RGD:4892562
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
G
CHUK
component of inhibitor of nuclear factor kappa B kinase complex
ISO
RGD
PMID:18643924
RGD:5133701
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
G
CSF3
colony stimulating factor 3
disease_progression treatment
IEP IDA
associated with Peritonitis;
RGD
PMID:21373266 PMID:12352049
RGD:5133733 , RGD:11039437
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CSF3R
colony stimulating factor 3 receptor
disease_progression
ISO
RGD
PMID:17185469
RGD:5133739
NCBI chr 1:36,466,043...36,483,314
Ensembl chr 1:36,466,043...36,483,278
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
RGD
PMID:21723409 PMID:11052817
RGD:5135062 , RGD:5135234
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
severity
ISO
RGD
PMID:16299319 PMID:15618188
RGD:5135458 , RGD:5135459
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL11
C-X-C motif chemokine ligand 11
ISO
RGD
PMID:15618188
RGD:5135459
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
G
CXCL2
C-X-C motif chemokine ligand 2
severity
ISO
RGD
PMID:19239431 PMID:11052817 PMID:21723409
RGD:5135065 , RGD:5135234 , RGD:5135062
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL3
C-X-C motif chemokine ligand 3
ISO
RGD
PMID:11052817
RGD:5135234
NCBI chr 4:74,036,589...74,038,689
Ensembl chr 4:74,036,589...74,038,807
G
CXCL5
C-X-C motif chemokine ligand 5
ISO
RGD
PMID:19846873
RGD:4145490
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
RGD
PMID:19846873
RGD:4145490
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
RGD
PMID:15618188
RGD:5135459
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:15618188
RGD:5135459
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
CYP2J2
cytochrome P450 family 2 subfamily J member 2
ISO
protein:decreased expression:lung
RGD
PMID:14766666
RGD:1625385
NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773
G
DEFB4A
defensin beta 4A
IEP
protein:increased expression:plasma
RGD
PMID:10213993
RGD:4892266
NCBI chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716 Ensembl chr 8:7,894,677...7,896,716
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21897338
RGD:6893486
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
FCGR2A
Fc gamma receptor IIa
ISO
RGD
PMID:17975174
RGD:5129707
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
FOXP3
forkhead box P3
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
GP1BA
glycoprotein Ib platelet subunit alpha
exacerbates
ISO
associated with Escherichia Coli Infections
RGD
PMID:27845343
RGD:42722624
NCBI chr17:4,932,277...4,935,023
Ensembl chr17:4,932,277...4,935,023
G
GRK2
G protein-coupled receptor kinase 2
IEP
mRNA:decreased expression:polymorphonuclear leukocyte
RGD
PMID:24465168
RGD:126848796
NCBI chr11:67,266,473...67,286,556
Ensembl chr11:67,266,473...67,286,556
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:lung (mouse)
RGD
PMID:19846873
RGD:4145490
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNAR1
interferon alpha and beta receptor subunit 1
severity
ISO
RGD
PMID:19487810 PMID:19487810
RGD:5490274 , RGD:5490274
NCBI chr21:33,324,395...33,359,864
Ensembl chr21:33,324,387...33,359,864
G
IFNG
interferon gamma
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL10
interleukin 10
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL15
interleukin 15
ISO
RGD
PMID:17911627
RGD:5000754
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL17A
interleukin 17A
severity
ISO
RGD
PMID:18802100 PMID:25398094
RGD:4889153 , RGD:38501102
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
ISO
RGD
PMID:17664259
RGD:4889913
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1B
interleukin 1 beta
severity treatment
ISO IDA
associated with Agranulocytosis
RGD
PMID:18596024 PMID:25398094 PMID:7546648
RGD:4143205 , RGD:38501102 , RGD:10755357
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
treatment
ISO
associated with Sepsis associated with Acinetobacter infectious disease
RGD
PMID:20959556 PMID:29508184
RGD:5144223 , RGD:40818077
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL1RN
interleukin 1 receptor antagonist
ISO
RGD
PMID:18322242 PMID:18596024
RGD:4143206 , RGD:4143205
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL22
interleukin 22
ISO
RGD
PMID:21178015
RGD:5147404
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
G
IL6
interleukin 6
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRAK3
interleukin 1 receptor associated kinase 3
ISO
RGD
PMID:28120642 PMID:20439918
RGD:34888234 , RGD:36049799
NCBI chr12:66,189,214...66,254,622
Ensembl chr12:66,189,195...66,254,622
G
IRF1
interferon regulatory factor 1
ISO
RGD
PMID:11854220
RGD:5128725
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
IRF3
interferon regulatory factor 3
ISO
RGD
PMID:20720199
RGD:4891951
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
G
ITGB3
integrin subunit beta 3
ISO
protein:increased expression:lung, neutrophil
RGD
PMID:15114484
RGD:4993468
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
G
LEP
leptin
ISO
RGD
PMID:11937559
RGD:5128871
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
MAPK8
mitogen-activated protein kinase 8
severity
ISO
associated with Escherichia Coli Infections
RGD
PMID:22514650
RGD:150340681
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MBL2
mannose binding lectin 2
IAGP
Legionella Pneumonia; DNA:mutations:5' utr, exon:multiple (human)
RGD
PMID:18641104
RGD:4889477
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MC1R
melanocortin 1 receptor
ISO
RGD
PMID:18304533
RGD:5687324
NCBI chr16:89,918,862...89,920,972
Ensembl chr16:89,912,119...89,920,973
G
MMP9
matrix metallopeptidase 9
ISO IEP
protein:increased expression:bronchoalveolar lavage fluid
RGD
PMID:17202364 PMID:19535150
RGD:5130727 , RGD:5129533
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MPO
myeloperoxidase
IEP
protein:increased activity:bronchoalveolar lavage Fluid:
RGD
PMID:11269653
RGD:5130992
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
NOD1
nucleotide binding oligomerization domain containing 1
ISO
RGD
PMID:19360122
RGD:5131449
NCBI chr 7:30,424,527...30,478,784
Ensembl chr 7:30,424,527...30,478,784
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
RGD
PMID:19360122
RGD:5131449
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
PDPN
podoplanin
ISO
protein:increased expression:lung
RGD
PMID:7864138
RGD:2292375
NCBI chr 1:13,583,757...13,617,957
Ensembl chr 1:13,583,465...13,617,957
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
protein:decreased expression:lung
RGD
PMID:12524254
RGD:724645
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PGF
placental growth factor
ISO
protein:increased expression:plasma
RGD
PMID:16702604
RGD:6483601
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
G
PTEN
phosphatase and tensin homolog
ameliorates
ISO
myeloid knockout
RGD
PMID:21527775
RGD:127285594
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
RIPK3
receptor interacting serine/threonine kinase 3
ameliorates
ISO
RGD
PMID:28387756
RGD:127229944
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
G
RORC
RAR related orphan receptor C
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
G
SERPINE1
serpin family E member 1
severity
ISO
RGD
PMID:17032919
RGD:4144840
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SFTPA1
surfactant protein A1
ISO
protein:increased expression:lung
RGD
PMID:12169586
RGD:4143464
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SFTPB
surfactant protein B
IEP ISO
associated with Cystic Fibrosis;protein:increased expression:lung
RGD
PMID:15271694 PMID:12169586
RGD:4143403 , RGD:4143464
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
G
SFTPC
surfactant protein C
ISO
RGD
PMID:18566429 PMID:12169586
RGD:4144114 , RGD:4143464
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
G
SFTPD
surfactant protein D
ISO IEP
protein:increased expression:lung associated with Cystic Fibrosis;protein:decreased expression:lung
RGD
PMID:12169586 PMID:15271694
RGD:4143464 , RGD:4143403
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
STAT3
signal transducer and activator of transcription 3
ISO
RGD
PMID:18192501
RGD:6892945
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
TGFB1
transforming growth factor beta 1
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TLR2
toll like receptor 2
ISO
RGD
PMID:18768871 PMID:19844782
RGD:4145337 , RGD:4889533
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
ISO
RGD
PMID:20650991 PMID:16210672
RGD:4144172 , RGD:4144197
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR5
toll like receptor 5
ISO
RGD
PMID:19801452
RGD:5129503
NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,248
G
TLR6
toll like receptor 6
ISO
RGD
PMID:19844782
RGD:4889533
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
G
TLR9
toll like receptor 9
ISO
RGD
PMID:20360853
RGD:5130719
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TNF
tumor necrosis factor
disease_progression treatment severity
IEP IDA ISO
associated with Agranulocytosis
RGD
PMID:10650487 PMID:7546648 PMID:9310939 PMID:12958055
RGD:4143476 , RGD:10755357 , RGD:10450564 , RGD:10449451
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
protein:increased expression:serum (mouse)
RGD
PMID:19842848
RGD:5131429
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
protein:increased expression:serum (mouse)
RGD
PMID:19842848
RGD:5131429
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
TREM1
triggering receptor expressed on myeloid cells 1
severity ameliorates
IEP ISO
RGD
PMID:24465168 PMID:16960786 PMID:22996209
RGD:126848796 , RGD:127229902 , RGD:126925987
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
ZC3H12A
zinc finger CCCH-type containing 12A
ISO
associated with Pseudomonas Infections
RGD
PMID:29695841
RGD:39938967
NCBI chr 1:37,474,580...37,484,377
Ensembl chr 1:37,474,580...37,484,377
G
ADRB2
adrenoceptor beta 2
IDA
RGD
PMID:17687719
RGD:4145098
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
G
CCL11
C-C motif chemokine ligand 11
severity
IEP ISO
protein:increased expression:nasal mucus associated with Respiratory Syncytial Virus Infections
RGD
PMID:17297249 PMID:15681407
RGD:4145460 , RGD:4145415
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CD40
CD40 molecule
IEP
RGD
PMID:19470255
RGD:5132271
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD86
CD86 molecule
ISO
protein:decreased expression:myeloid dendritic cell (mouse)
RGD
PMID:20046053
RGD:4892291
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CRP
C-reactive protein
severity
IEP
RGD
PMID:21284715
RGD:5131282
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CYSLTR1
cysteinyl leukotriene receptor 1
ISO
associated with Pneumovirus Infections
RGD
PMID:16337014
RGD:4843953
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
G
IL17A
interleukin 17A
susceptibility
IAGP
DNA:SNP:promoter:rs2275913 (human)
RGD
PMID:20437253
RGD:4889139
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1B
interleukin 1 beta
IEP
protein:increased expression:lung
RGD
PMID:8608647
RGD:4143192
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
IEP
protein:increased expression:lung
RGD
PMID:8608647
RGD:4143192
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
IAGP
DNA:polymorphisms:promoter:rs885454,rs17235353, rs7115457 (human)
RGD
PMID:15709052
RGD:7349353
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
G
ACE
angiotensin I converting enzyme
ISO
RGD
PMID:17097496
RGD:4140933
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ADORA2A
adenosine A2a receptor
ISO
RGD
PMID:19766783
RGD:4890362
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
CCL17
C-C motif chemokine ligand 17
IEP
RGD
PMID:18785972
RGD:4145604
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
G
CCL2
C-C motif chemokine ligand 2
ISO
RGD
PMID:14611812
RGD:2307195
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL22
C-C motif chemokine ligand 22
IEP
RGD
PMID:20628341
RGD:4891471
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:lung (rat)
RGD
PMID:19840961 PMID:14611812
RGD:4889978 , RGD:2307195
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCL7
C-C motif chemokine ligand 7
ISO
protein:increased expression:bronchoalveolar Lavage fluid
RGD
PMID:22215510
RGD:6483763
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
CCR2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:trachea:
RGD
PMID:11518728
RGD:4145124
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CD86
CD86 molecule
ISO
RGD
PMID:11266944
RGD:2307206
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CSF2
colony stimulating factor 2
ISO
associated with Respiratory Aspiration;protein:increased expression:serum
RGD
PMID:18557728
RGD:2317286
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CXCL10
C-X-C motif chemokine ligand 10
ISO IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:16709871 PMID:12097412 PMID:12097412
RGD:5135441 , RGD:5135451 , RGD:5135451
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL11
C-X-C motif chemokine ligand 11
ISO IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:12097412 PMID:12097412
RGD:5135451 , RGD:5135451
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
G
CXCL9
C-X-C motif chemokine ligand 9
ISO IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:16709871 PMID:12097412 PMID:12097412
RGD:5135441 , RGD:5135451 , RGD:5135451
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:16709871 PMID:12097412
RGD:5135441 , RGD:5135451
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
EDN1
endothelin 1
IMP
human gene in a rat model
RGD
PMID:9595474
RGD:8662402
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
FOXP3
forkhead box P3
ISO
mRNA:increased expression:lung
RGD
PMID:19840961
RGD:4889978
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
GZMB
granzyme B
IEP
RGD
PMID:19737140
RGD:5135518
NCBI chr14:24,630,954...24,634,190
Ensembl chr14:24,630,954...24,634,267
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:12973103
RGD:4145412
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
IFNG
interferon gamma
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16137903
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL13
interleukin 13
ISO IEP
protein:increased expression:bronchoalveolar lavage fluid
RGD
PMID:17182591 PMID:17182591
RGD:4146242 , RGD:4146242
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL13RA1
interleukin 13 receptor subunit alpha 1
ISO
RGD
PMID:17182591
RGD:4146242
NCBI chr X:118,727,606...118,805,228
Ensembl chr X:118,727,133...118,794,535
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO
RGD
PMID:17182591
RGD:4146242
NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977
G
IL17A
interleukin 17A
ISO
mRNA:increased expression:trachea
RGD
PMID:20393404
RGD:4143277
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1RN
interleukin 1 receptor antagonist
IEP
protein:increased expression:lung
RGD
PMID:11889437
RGD:4143176
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL4
interleukin 4
ISO
protein:increased expression:serum
RGD
PMID:18557728
RGD:2317286
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
ISO
RGD
PMID:20393404
RGD:4143277
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
MBL2
mannose binding lectin 2
resistance
IAGP
DNA:transversion:5' utr:-290C>G rs7096206 (human)
RGD
PMID:19104434
RGD:4889456
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MMP9
matrix metallopeptidase 9
IEP
protein:increased expression, increased activity:bronchoalveolar lavage fluid
RGD
PMID:20417130
RGD:5130759
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MUC1
mucin 1, cell surface associated
IEP
protein:increased expression:serum
RGD
PMID:16969297
RGD:5131273
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
NOD2
nucleotide binding oligomerization domain containing 2
IAGP
RGD
PMID:18158963
RGD:5131450
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
NOS2
nitric oxide synthase 2
IEP
associated with lung transplantation; protein:increased expression:lung
RGD
PMID:11112135
RGD:4892082
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
ISO
protein:increased expression:lung
RGD
PMID:15136885
RGD:4892068
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
SCGB1A1
secretoglobin family 1A member 1
IEP
associated with lung transplantation; protein:decreased expression:serum,bronchoalveolar lavage
RGD
PMID:11981419
RGD:5147386
NCBI chr11:62,419,033...62,423,195
Ensembl chr11:62,405,103...62,423,195
G
SFTPD
surfactant protein D
IEP
RGD
PMID:18347569
RGD:4143500
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
TLR9
toll like receptor 9
IAGP
DNA:SNPs:promoter, 3' utr:g.-1485C>T (rs187084), rs352162 (human)
RGD
PMID:20227302
RGD:5130722
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
IAGP
DNA:polymorphism (human)
RGD
PMID:14593914
RGD:4889126
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
EGR1
early growth response 1
ISO
RGD
PMID:17384085
RGD:5132266
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
HDAC2
histone deacetylase 2
treatment
ISO
RGD
PMID:22708526
RGD:9590258
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
G
IFNG
interferon gamma
resistance
ISO
RGD
PMID:20953328
RGD:4145525
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
CCL5
C-C motif chemokine ligand 5
IEP
protein:increased secretion:serum (human)
RGD
PMID:20350425
RGD:4892019
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CXCR2
C-X-C motif chemokine receptor 2
disease_progression
ISO
associated with Plague
RGD
PMID:21356370
RGD:5134954
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
G
MBL2
mannose binding lectin 2
IEP
associated with Down Syndrome; protein:decreased secretion:serum (human)
RGD
PMID:19804807
RGD:4889483
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
CD274
CD274 molecule
ISO
mRNA:increased expression:lung
RGD
PMID:26378990
RGD:41412180
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
PDCD1
programmed cell death 1
ISO
mRNA:increased expression:lung
RGD
PMID:26378990
RGD:41412180
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
severity
ISO
RGD
PMID:29893841
RGD:40890270
NCBI chr 1:9,627,258...9,729,114
Ensembl chr 1:9,629,889...9,729,114
G
CCL11
C-C motif chemokine ligand 11
IEP
RGD
PMID:11991282
RGD:4145442
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CFTR
CF transmembrane conductance regulator
susceptibility
IAGP
associated with pulmonary disease chronic obstructive; DNA:missense mutation:exon:p.R75Q(human) DNA:deletion: :F508del(human)
RGD
PMID:15463907 PMID:10767489
RGD:4140475 , RGD:4140484
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
IAGP
DNA:SNPs: :multiple (human)
RGD
PMID:19386687
RGD:4891509
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
susceptibility
IAGP
DNA:polymorphism (human)
RGD
PMID:15928955
RGD:4142512
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
IAGP
DNA:polymorphism (human)
RGD
PMID:14593914
RGD:4889126
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
EDN1
endothelin 1
ISO
Chronic Allergic Airway Inflammation; protein:increased secretion:bronchoalveolar lavage (mouse)
RGD
PMID:18631350
RGD:4145074
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
GC
GC vitamin D binding protein
susceptibility
IAGP
RGD
PMID:12096683
RGD:5129516
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
GSTM1
glutathione S-transferase mu 1
severity
IAGP
DNA:deletion: : DNA:deletion, haplotype: : (human)
RGD
PMID:9187680 PMID:15125256
RGD:4142513 , RGD:12798508
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTT1
glutathione S-transferase theta 1
susceptibility
IAGP
DNA:deletion: :
RGD
PMID:15928955
RGD:4142512
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:bronchial epithelium (rat)
RGD
PMID:19507274
RGD:2308951
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IL10
interleukin 10
ISO
protein:decreased expression:lung
RGD
PMID:19507274
RGD:2308951
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL13
interleukin 13
IEP
protein:increased expression:Respiratory Mucosa
RGD
PMID:14582911
RGD:4759835
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL15
interleukin 15
IEP
mRNA, protein:increased expression:lung
RGD
PMID:11742275
RGD:4990461
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
MPO
myeloperoxidase
ISO
protein:increased expression:lung
RGD
PMID:11798689
RGD:5130990
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:19938219
RGD:4891494
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NPY
neuropeptide Y
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9731035
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
VEGFA
vascular endothelial growth factor A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19263519
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
EDN1
endothelin 1
IEP
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human)
RGD
PMID:8845175
RGD:8661738
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
CD8A
CD8 subunit alpha
ameliorates
IEP
protein:decreased expression:blood, T cell (human)
RGD
PMID:24639246
RGD:124715444
NCBI chr 2:86,784,605...86,808,396
Ensembl chr 2:86,784,610...86,808,396
G
IL17A
interleukin 17A
IEP
protein:increased expression:uncinate process, nasal mucosa (human)
RGD
PMID:23613503
RGD:8696039
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1RN
interleukin 1 receptor antagonist
susceptibility
IAGP
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human)
RGD
PMID:16549749
RGD:8549791
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
MBL2
mannose binding lectin 2
IEP
protein:decreased activity:serum:
RGD
PMID:23144819
RGD:8693716
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
PRG2
proteoglycan 2, pro eosinophil major basic protein
disease_progression
IEP
associated with Nasal Polyps;
RGD
PMID:24450586
RGD:13506943
NCBI chr11:57,386,780...57,390,650
Ensembl chr11:57,386,780...57,390,650
G
ALOX5
arachidonate 5-lipoxygenase
IEP
protein:increased expression:bronchus
RGD
PMID:11865407
RGD:4890421
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
IEP
protein:increased expression:bronchus
RGD
PMID:11865407
RGD:4890421
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
G
CX3CL1
C-X3-C motif chemokine ligand 1
IDA
RGD
PMID:20696083
RGD:4140458
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
CXCL1
C-X-C motif chemokine ligand 1
IEP
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell
RGD
PMID:20395558
RGD:4145446
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:15764644
RGD:5135489
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL5
C-X-C motif chemokine ligand 5
IEP
associated with Asthma
RGD
PMID:12751040
RGD:5135264
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL8
C-X-C motif chemokine ligand 8
treatment
IEP
RGD
PMID:28343401
RGD:150521550
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:19864593
RGD:5131210
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
G
DEFB4A
defensin beta 4A
IEP
mRNA, protein:increased expression:nasal cavity epithelium, nasal mucus
RGD
PMID:15034083
RGD:4892264
NCBI chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716 Ensembl chr 8:7,894,677...7,896,716
G
IFNA2
interferon alpha 2
treatment
IDA
RGD
PMID:6381610
RGD:40886344
NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398
G
IL10
interleukin 10
IDA
RGD
PMID:20696083
RGD:4140458
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL1A
interleukin 1 alpha
IEP
protein:increased expression:nasal mucus
RGD
PMID:10358201
RGD:4143183
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
IEP
protein:increased expression:nasal mucus
RGD
PMID:7734976
RGD:7401200
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
IEP IDA
protein:increased expression:nasal mucus
RGD
PMID:10358201 PMID:18279051
RGD:4143183 , RGD:4143207
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL33
interleukin 33
IEP
protein:increased expression:nasal mucus
RGD
PMID:28471975
RGD:38596342
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
IL4
interleukin 4
ISO
associated with Asthma;mRNA, protein:increased expression:alveolar macrophage, respiratory system fluid/secretion
RGD
PMID:20644177
RGD:4140459
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
PRDX5
peroxiredoxin 5
IEP
associated with asthma;protein:increased expression:sputum (human)
RGD
PMID:18219526
RGD:41404684
NCBI chr11:64,318,121...64,321,811
Ensembl chr11:64,318,121...64,321,811
G
TSLP
thymic stromal lymphopoietin
IEP
protein:increased expression:nasal mucus (human)
RGD
PMID:28471975
RGD:38596342
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
G
TNFRSF1A
TNF receptor superfamily member 1A
IEP
protein:increased expression:lung, macrophage (human)
RGD
PMID:21144722
RGD:5131112
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFRSF1B
TNF receptor superfamily member 1B
IEP
protein:increased expression:lung, lymphocyte (human)
RGD
PMID:21144722
RGD:5131112
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
SFTPC
surfactant protein C
ISS
OMIM:263000
MouseDO
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
G
HLA-B
major histocompatibility complex, class I, B
susceptibility
IAGP
DNA:polymorphism:cds:HLA-B*5401 (human)
RGD
PMID:9731015
RGD:1331522
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
MBL2
mannose binding lectin 2
susceptibility
IAGP
DNA:SNP:exon:p.G54D(rs1800450)(human)
RGD
PMID:15249448
RGD:8693755
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
IEP
protein:decreased expression:bronchiole epithelium
RGD
PMID:15364771
RGD:7364741
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
IAGP
DNA:insertion/deletion
RGD
PMID:15709052
RGD:7349353
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
G
MUCL3
mucin like 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22152429
NCBI chr 6:30,940,973...30,954,221
Ensembl chr 6:30,934,523...30,954,221
G
TAP2
transporter 2, ATP binding cassette subfamily B member
susceptibility
IAGP
DNA:polymorphisms:exon:
RGD
PMID:10323341
RGD:5147847
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
G
CCL7
C-C motif chemokine ligand 7
IEP
protein:increased expression:ethmoid sinus
RGD
PMID:9800627
RGD:6483785
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
C5
complement C5
ISO
RGD
PMID:2612053
RGD:5130160
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
CCL7
C-C motif chemokine ligand 7
ISO
RGD
PMID:20045013
RGD:5129686
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
GATA2
GATA binding protein 2
ISO
associated with Pneumocystis Infections
RGD
PMID:16774119
RGD:9587813
NCBI chr 3:128,479,422...128,493,201
Ensembl chr 3:128,479,427...128,493,201
G
IL13
interleukin 13
ISO
protein:increased expression:lung
RGD
PMID:19752036 PMID:16544260
RGD:4145474 , RGD:4145506
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL33
interleukin 33
ISO
protein:increased expression:lung
RGD
PMID:25746970
RGD:39938968
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
NOS2
nitric oxide synthase 2
ISO
protein:decreased expression:lung
RGD
PMID:10639453
RGD:4891455
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
SFTPA1
surfactant protein A1
susceptibility
ISO
RGD
PMID:20413160
RGD:4143489
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SFTPD
surfactant protein D
susceptibility
ISO IDA
RGD
PMID:20413160 PMID:20413160
RGD:4143489 , RGD:4143489
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
TNF
tumor necrosis factor
ISO
protein:increased expression:lung
RGD
PMID:16544260
RGD:4145506
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
susceptibility
IAGP
DNA:polymorphism:cds:allele AB (human)
RGD
PMID:6189297 PMID:4375858
RGD:5128836 , RGD:39938844
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
G
APOL6
apolipoprotein L6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr22:35,648,446...35,668,404
Ensembl chr22:35,648,446...35,668,404
G
ATF3
activating transcription factor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
C3
complement C3
ISO
RGD
PMID:21408070
RGD:5129492
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CASP1
caspase 1
ISO
RGD
PMID:19362023
RGD:5130181
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CAT
catalase
ISO IDA
RGD
PMID:16804020 PMID:20653246 PMID:19959187
RGD:5130864 , RGD:5130201 , RGD:5130744
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL11
C-C motif chemokine ligand 11
ISO
associated with Asthma;protein:increased expression:respiratory system fluid/secretion
RGD
PMID:12707338 PMID:20656925
RGD:4145439 , RGD:4145452
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL2
C-C motif chemokine ligand 2
ISO EXP
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23326326 PMID:20967263
RGD:4891425
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL28
C-C motif chemokine ligand 28
resistance
ISO
RGD
PMID:19847203
RGD:4892196
NCBI chr 5:43,356,975...43,412,391
Ensembl chr 5:43,376,645...43,412,391
G
CCL5
C-C motif chemokine ligand 5
susceptibility
ISO
protein:increased expression:lung (mouse)
RGD
PMID:20656925 PMID:16208318
RGD:4145452 , RGD:4892131
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCL8
C-C motif chemokine ligand 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
G
CCR5
C-C motif chemokine receptor 5
severity
ISO IAGP
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:19039768 PMID:18617426 PMID:20875295
RGD:4892119 , RGD:4892122 , RGD:4892063
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CD14
CD14 molecule
ISO
RGD
PMID:17825924
RGD:4144809
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD209
CD209 molecule
susceptibility
IEP
RGD
PMID:21191006
RGD:5131189
NCBI chr19:7,739,993...7,747,534
Ensembl chr19:7,739,993...7,747,564
G
CD28
CD28 molecule
ISO
RGD
PMID:21389258
RGD:5131611
NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,475...203,738,912
G
CD40
CD40 molecule
ISO
RGD
PMID:19922665
RGD:5132270
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD80
CD80 molecule
ISO
RGD
PMID:19922665 PMID:10604996
RGD:5132270 , RGD:5132623
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
G
CD86
CD86 molecule
ISO
protein:increased expression:mediastinal lymph node, B cell (mouse)
RGD
PMID:19933871
RGD:4892570
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CRP
C-reactive protein
IEP
protein:increased expression:serum
RGD
PMID:21509252
RGD:5131277
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CSF2
colony stimulating factor 2
ISO IDA
RGD
PMID:21474645 PMID:20427198
RGD:5131470 , RGD:5131472
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
protein:increased expression:respiratory system fluid/secretion protein:increased expression:lung, serum
RGD
PMID:20656925 PMID:17348295
RGD:4145452 , RGD:4145366
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL2
C-X-C motif chemokine ligand 2
ISO
mRNA:increased expression:lung
RGD
PMID:21251691 PMID:20967263
RGD:5135026 , RGD:4891425
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
DDX60
DExD/H-box helicase 60
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 4:168,216,294...168,325,979
Ensembl chr 4:168,216,291...168,318,883
G
EGR1
early growth response 1
ISO
mRNA:increased expression:frontal cortex (mouse)
RGD
PMID:21289196
RGD:5131660
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EIF2AK2
eukaryotic translation initiation factor 2 alpha kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 2:37,099,210...37,156,980
Ensembl chr 2:37,099,210...37,157,522
G
FOXP2
forkhead box P2
ISO
RGD
PMID:18248790
RGD:11536002
NCBI chr 7:114,086,327...114,693,765
Ensembl chr 7:114,086,327...114,693,772
G
GBP1
guanylate binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360
G
HERC5
HECT and RLD domain containing E3 ubiquitin protein ligase 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 4:88,457,119...88,506,163
Ensembl chr 4:88,457,119...88,506,163
G
HERC6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 4:88,378,852...88,443,097
Ensembl chr 4:88,378,739...88,443,097
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
IMP
RGD
PMID:19386707
RGD:4144816
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HLA-G
major histocompatibility complex, class I, G
IEP
RGD
PMID:21087648
RGD:5144131
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
G
IFI27
interferon alpha inducible protein 27
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr14:94,105,894...94,116,690
Ensembl chr14:94,104,836...94,116,695
G
IFI35
interferon induced protein 35
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456
G
IFI44
interferon induced protein 44
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 1:78,649,789...78,664,078
Ensembl chr 1:78,649,796...78,664,078
G
IFI44L
interferon induced protein 44 like
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 1:78,620,448...78,646,145
Ensembl chr 1:78,619,902...78,646,145
G
IFI6
interferon alpha inducible protein 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212
G
IFIH1
interferon induced with helicase C domain 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
G
IFIT1
interferon induced protein with tetratricopeptide repeats 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
G
IFIT2
interferon induced protein with tetratricopeptide repeats 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr10:89,302,046...89,309,271
Ensembl chr10:89,283,694...89,309,271
G
IFIT3
interferon induced protein with tetratricopeptide repeats 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr10:89,327,997...89,340,968
Ensembl chr10:89,327,307...89,377,473
G
IFIT5
interferon induced protein with tetratricopeptide repeats 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr10:89,414,568...89,420,997
Ensembl chr10:89,414,568...89,421,605
G
IFITM3
interferon induced transmembrane protein 3
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Influenza, severe, susceptibility to
CTD ClinVar OMIM
PMID:20943977 PMID:22446628 PMID:23326326
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
G
IL10
interleukin 10
susceptibility
ISO
RGD
PMID:20200252
RGD:4140426
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL12B
interleukin 12B
ISO
RGD
PMID:16389596
RGD:4145426
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
IL13
interleukin 13
IEP
protein:increased expression:serum
RGD
PMID:20003352
RGD:4888530
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL15
interleukin 15
IMP ISO
mRNA, protein:increased expression:lung
RGD
PMID:19234203 PMID:21098221 PMID:20212069
RGD:4996472 , RGD:4994196 , RGD:4996471
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL15RA
interleukin 15 receptor subunit alpha
ISO
RGD
PMID:21098221
RGD:4994196
NCBI chr10:5,948,900...5,978,741
Ensembl chr10:5,943,639...5,978,187
G
IL17A
interleukin 17A
ISO
mRNA, protein:increased expression:lung
RGD
PMID:19783685 PMID:19265125
RGD:4889102 , RGD:4889150
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL17RA
interleukin 17 receptor A
ISO
RGD
PMID:19783685
RGD:4889102
NCBI chr22:17,085,000...17,115,693
Ensembl chr22:17,084,954...17,115,693
G
IL18
interleukin 18
ISO
RGD
PMID:15606801
RGD:4889964
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
ISO
protein:increased expression:lung
RGD
PMID:11535264
RGD:4142860
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
ISO
RGD
PMID:20438620
RGD:4142822
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
disease_progression
IEP IDA
protein:increased expression:serum
RGD
PMID:20840779 PMID:9439800
RGD:4143203 , RGD:4143228
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2
interleukin 2
IEP
protein:increased expression:serum
RGD
PMID:21603856
RGD:5147905
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL22
interleukin 22
ISO
RGD
PMID:21178015 PMID:20504940
RGD:5147404 , RGD:5147405
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
G
IL4
interleukin 4
ISO
RGD
PMID:21092162
RGD:5128546
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
ISO
RGD
PMID:20731583
RGD:4143268
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRF7
interferon regulatory factor 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983
G
ISG15
ISG15 ubiquitin like modifier
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 1:1,013,497...1,014,540
Ensembl chr 1:1,001,138...1,014,540
G
LAMP3
lysosomal associated membrane protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:183,122,215...183,163,813
Ensembl chr 3:183,122,215...183,163,839
G
LY6E
lymphocyte antigen 6 family member E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 8:143,018,529...143,022,409
Ensembl chr 8:143,017,982...143,023,832
G
LYST
lysosomal trafficking regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26597256
NCBI chr 1:235,661,031...235,883,713
Ensembl chr 1:235,661,041...235,883,724
G
MMP9
matrix metallopeptidase 9
ISO
protein:increased activity:lung, heart, brain
RGD
PMID:20299740
RGD:5130855
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MX1
MX dynamin like GTPase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
G
MX2
MX dynamin like GTPase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr21:41,362,027...41,409,393
Ensembl chr21:41,361,999...41,409,393
G
NOS1
nitric oxide synthase 1
ISO
protein:increased expression:hippocampus
RGD
PMID:9552178
RGD:5132870
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
G
NOS2
nitric oxide synthase 2
ISO
mRNA:increased expression:olfactory epithelium mRNA,protein:increased expression:brain
RGD
PMID:17674769 PMID:18080188 PMID:17030871
RGD:4891919 , RGD:4891937 , RGD:4891952
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
OAS1
2'-5'-oligoadenylate synthetase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219
G
OAS2
2'-5'-oligoadenylate synthetase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr12:112,978,519...113,011,723
Ensembl chr12:112,978,395...113,011,723
G
OAS3
2'-5'-oligoadenylate synthetase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr12:112,938,474...112,973,251
Ensembl chr12:112,938,051...112,976,460
G
OASL
2'-5'-oligoadenylate synthetase like
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr12:121,017,761...121,039,246
Ensembl chr12:121,017,763...121,039,246
G
PARP12
poly(ADP-ribose) polymerase family member 12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 7:140,023,749...140,062,951
Ensembl chr 7:140,023,749...140,062,951
G
PLSCR1
phospholipid scramblase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:146,515,180...146,544,607
Ensembl chr 3:146,515,180...146,544,856
G
PRF1
perforin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26597256
NCBI chr10:70,597,348...70,602,741
Ensembl chr10:70,597,348...70,602,759
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:16272346
RGD:5143925
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
RIGI
RNA sensor RIG-I
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,208
G
RSAD2
radical S-adenosyl methionine domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239
G
RTP4
receptor transporter protein 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:187,368,385...187,372,076
Ensembl chr 3:187,368,385...187,372,076
G
SAMD9
sterile alpha motif domain containing 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 7:93,099,518...93,117,979
Ensembl chr 7:93,099,513...93,118,023
G
SCO2
synthesis of cytochrome C oxidase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr22:50,523,568...50,526,442
Ensembl chr22:50,523,568...50,526,461
G
SERPING1
serpin family G member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
G
SFTPD
surfactant protein D
ISO
RGD
PMID:16787926
RGD:4143518
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
SIGLEC1
sialic acid binding Ig like lectin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr20:3,686,970...3,712,600
Ensembl chr20:3,686,970...3,712,600
G
SLC22A8
solute carrier family 22 member 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23129053
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
STAT1
signal transducer and activator of transcription 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
TDRD7
tudor domain containing 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 9:97,412,096...97,496,125
Ensembl chr 9:97,412,096...97,496,125
G
TLR2
toll like receptor 2
IEP
protein:increased expression:monocyte
RGD
PMID:18657324
RGD:4145339
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR3
toll like receptor 3
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:16789835 PMID:18654661
RGD:5129219 , RGD:5129136
NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073
G
TMPRSS11D
transmembrane serine protease 11D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20237084 PMID:23072892
NCBI chr 4:67,820,876...67,884,002
Ensembl chr 4:67,820,876...67,884,002
G
TMPRSS2
transmembrane serine protease 2
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:20237084 PMID:21123387 PMID:23072892 PMID:26889029 PMID:28778717 PMID:31391268 More...
NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
G
TMPRSS4
transmembrane serine protease 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26889029
NCBI chr11:118,077,078...118,125,505
Ensembl chr11:118,077,012...118,121,890
G
TNF
tumor necrosis factor
IEP
protein:increased expression:serum
RGD
PMID:21062445
RGD:5128683
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP6
TNF alpha induced protein 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO IEP
protein:increased expression:serum (human)
RGD
PMID:17182684 PMID:19497758
RGD:5131157 , RGD:5131432
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFSF10
TNF superfamily member 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TOR1B
torsin family 1 member B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 9:129,803,184...129,811,281
Ensembl chr 9:129,803,157...129,811,281
G
TREX1
three prime repair exonuclease 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:48,465,830...48,467,645
Ensembl chr 3:48,465,811...48,467,645
G
TRIM22
tripartite motif containing 22
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr11:5,689,790...5,710,863
Ensembl chr11:5,689,610...5,737,089
G
UBE2L6
ubiquitin conjugating enzyme E2 L6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr11:57,551,662...57,567,935
Ensembl chr11:57,551,656...57,568,284
G
UGCG
UDP-glucose ceramide glucosyltransferase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33639165
NCBI chr 9:111,896,814...111,935,369
Ensembl chr 9:111,896,814...111,935,369
G
XAF1
XIAP associated factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr17:6,755,447...6,775,647
Ensembl chr17:6,755,447...6,775,647
G
XIST
X inactive specific transcript
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr X:73,820,651...73,852,753
Ensembl chr X:73,820,649...73,852,723
G
ZCCHC2
zinc finger CCHC-type containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr18:62,523,025...62,586,729
Ensembl chr18:62,523,025...62,587,709
G
CXCL5
C-X-C motif chemokine ligand 5
IEP
associated with Scleroderma, Diffuse protein:increased expression:serum
RGD
PMID:18432520 PMID:16085216
RGD:5135258 , RGD:5135260
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
ICAM1
intercellular adhesion molecule 1
IEP
protein:increased expression:lung, alveolar macrophage (human)
RGD
PMID:19218648
RGD:4145518
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IL6
interleukin 6
ISO
protein:increased expression:bronchoalveolar lavage (rat)
RGD
PMID:10988147
RGD:11062092
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
KEAP1
kelch like ECH associated protein 1
IEP
protein:increased expression:hyperplastic lung epithelium, alveolus (human)
RGD
PMID:20718723
RGD:6893300
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
G
MTOR
mechanistic target of rapamycin kinase
IMP
RGD
PMID:21444868
RGD:7245946
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
SCGB1A1
secretoglobin family 1A member 1
IEP
protein:increased expression:serum
RGD
PMID:15467329
RGD:5144148
NCBI chr11:62,419,033...62,423,195
Ensembl chr11:62,405,103...62,423,195
G
ABCA3
ATP binding cassette subfamily A member 3
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:15976379 PMID:17597647 PMID:18024538 PMID:18246475 PMID:18317237 PMID:18603241 PMID:18676873 PMID:22145626 PMID:22304854 PMID:22434821 PMID:22435821 PMID:22800827 PMID:22866751 PMID:23166334 PMID:23625987 PMID:24033266 PMID:24136335 PMID:24871971 PMID:25073622 PMID:25553246 PMID:25741868 PMID:27374344 PMID:27516224 PMID:28034695 PMID:28492532 PMID:28642621 PMID:29431110 PMID:29505158 PMID:29566461 PMID:30609409 PMID:30755392 PMID:31589614 PMID:31980526 PMID:32238781 PMID:32532878 PMID:32692933 PMID:33110422 PMID:33526094 PMID:34132118 PMID:34715861 PMID:35170262 PMID:35626240 More...
NCBI chr16:2,275,881...2,340,728
Ensembl chr16:2,275,881...2,340,746
G
AHRR
aryl hydrocarbon receptor repressor
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:321,714...438,285
Ensembl chr 5:321,714...438,291
G
AKT1
AKT serine/threonine kinase 1
IEP
mRNA:increased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
APOA1
apolipoprotein A1
IEP
protein: decreased expression: respiratory system fluid/secretion
RGD
PMID:20463180
RGD:5508222
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
G
ATP11A
ATPase phospholipid transporting 11A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23583980
NCBI chr13:112,690,038...112,887,168
Ensembl chr13:112,690,038...112,887,168
G
BMP1
bone morphogenetic protein 1
IAGP
ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr 8:22,165,372...22,212,326
Ensembl chr 8:22,165,140...22,212,326
G
BRD4
bromodomain containing 4
IDA
RGD
PMID:23759512
RGD:9586353
NCBI chr19:15,235,519...15,332,539
Ensembl chr19:15,235,519...15,332,545
G
BRD9
bromodomain containing 9
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:863,741...892,801
Ensembl chr 5:850,291...892,801
G
CCL13
C-C motif chemokine ligand 13
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28434932
NCBI chr17:34,356,480...34,358,610
Ensembl chr17:34,356,480...34,358,610
G
CEP72
centrosomal protein 72
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:612,340...676,616
Ensembl chr 5:612,340...667,168
G
CFLAR
CASP8 and FADD like apoptosis regulator
IEP
mRNA,protein:increased expression:lung myofibroblast:
RGD
PMID:22582174
RGD:11341695
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
G
CTC1
CST telomere replication complex component 1
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr17:8,224,815...8,248,056
Ensembl chr17:8,224,815...8,248,058
G
CXCL5
C-X-C motif chemokine ligand 5
IAGP IEP
DNA:polymorphism:promoter:-156G>C (human) protein:increased expression:lung, macrophage, type II pneumocyte
RGD
PMID:20137269 PMID:11751193
RGD:5135241 , RGD:5135250
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
DDR1
discoidin domain receptor tyrosine kinase 1
treatment
IEP ISO
mRNA:increased expression:lung (human)
RGD
PMID:30119248 PMID:30119248
RGD:151347411 , RGD:151347411
NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
G
DPP9
dipeptidyl peptidase 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23583980
NCBI chr19:4,675,227...4,723,842
Ensembl chr19:4,674,341...4,724,673
G
DSP
desmoplakin
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Interstitial lung disease 2
CTD ClinVar
PMID:23583980
NCBI chr 6:7,541,671...7,586,714
Ensembl chr 6:7,541,338...7,586,714
G
DTNBP1
dystrobrevin binding protein 1
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr 6:15,522,807...15,663,058
Ensembl chr 6:15,522,807...15,663,058
G
EHMT2
euchromatic histone lysine methyltransferase 2
IDA
RGD
PMID:24652950
RGD:9589169
NCBI chr 6:31,879,759...31,897,698
Ensembl chr 6:31,879,759...31,897,698
G
EP300
E1A binding protein p300
treatment
IEP ISO
mRNA:increased expression:lung (human)
RGD
PMID:30119248 PMID:30119248
RGD:151347411 , RGD:151347411
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,592...41,180,077
G
ESR1
estrogen receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30165855
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
EXOC3
exocyst complex component 3
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:443,176...467,290
Ensembl chr 5:443,175...471,937
G
EXOC3-AS1
EXOC3 antisense RNA 1
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:441,835...443,160
Ensembl chr 5:441,498...443,160
G
F3
coagulation factor III, tissue factor
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:10946084
RGD:11060143
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
FAM13A
family with sequence similarity 13 member A
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Interstitial lung disease 2
CTD ClinVar
PMID:23583980
NCBI chr 4:88,725,960...89,057,185
Ensembl chr 4:88,725,955...89,111,398
G
FAS
Fas cell surface death receptor
ISO
RGD
PMID:15148335
RGD:11049166
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASLG
Fas ligand
ISO
RGD
PMID:15148335
RGD:11049166
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FGFR2
fibroblast growth factor receptor 2
IEP
protein:increased expression:lung (human)
RGD
PMID:29722558
RGD:155791445
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
G
GPER1
G protein-coupled estrogen receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30165855
NCBI chr 7:1,087,118...1,093,810
Ensembl chr 7:1,082,208...1,093,815
G
HIF1A
hypoxia inducible factor 1 subunit alpha
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:28434932
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility
IAGP
DNA:polymorphism (human)
RGD
PMID:21373184
RGD:5147566
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HPS4
HPS4 biogenesis of lysosomal organelles complex 3 subunit 2
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr22:26,443,109...26,483,863
Ensembl chr22:26,443,107...26,483,931
G
IL1RL1
interleukin 1 receptor like 1
IEP
protein:increased expression:serum
RGD
PMID:14555548
RGD:5144236
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL1RN
interleukin 1 receptor antagonist
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:16199547 PMID:19494218 PMID:21792839 PMID:22940634 PMID:26100510 PMID:28492532 More...
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2RA
interleukin 2 receptor subunit alpha
IEP
RGD
PMID:21309737
RGD:5147438
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
G
LAMA3
laminin subunit alpha 3
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr18:23,689,453...23,955,066
Ensembl chr18:23,689,453...23,956,222
G
LOC110806263
TERT 5' regulatory region
IAGP
ClinVar Annotator: match by term: Idiopathic Pulmonary Fibrosis ClinVar Annotator: match by term: Idiopathic Pulmonary Fibrosis | ClinVar Annotator: match by term: Idiopathic fibrosing alveolitis, chronic form | ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:16199547 PMID:16247010 PMID:17392301 PMID:17460043 PMID:19489057 PMID:20301779 PMID:24033266 PMID:25741868 PMID:28492532 PMID:31268371 More...
NCBI chr 5:1,294,628...1,298,988
G
LOC110806264
TERT enhancer in intron 2
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:28492532
NCBI chr 5:1,286,474...1,287,720
G
LOC110806306
telomerase RNA component (TERC) promoter
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:17392301
NCBI chr 3:169,764,689...169,765,858
G
LOC123493259
Sharpr-MPRA regulatory region 13256
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:28492532
NCBI chr 5:1,276,694...1,276,988
G
LOC129999976
ATAC-STARR-seq lymphoblastoid silent region 18982
IAGP
ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
G
MIR184
microRNA 184
IEP
RNA:decreased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr15:79,209,788...79,209,871
Ensembl chr15:79,209,788...79,209,871
G
MIR31
microRNA 31
IEP
RNA:increased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr 9:21,512,115...21,512,185
Ensembl chr 9:21,512,115...21,512,185
G
MMP1
matrix metallopeptidase 1
IEP IAGP
protein:increased expression:lung,bronchoalveolar lavage fluid: ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar RGD
PMID:18447576
RGD:4890373
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP19
matrix metallopeptidase 19
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr12:55,835,433...55,842,936
Ensembl chr12:55,835,433...55,842,966
G
MMP3
matrix metallopeptidase 3
IEP EXP
mRNA, protein:increased expression:lung CTD Direct Evidence: therapeutic
CTD RGD
PMID:28434932 PMID:21871427
RGD:8694097
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MUC1
mucin 1, cell surface associated
IEP
protein:increased expression:serum:
RGD
PMID:22963039
RGD:7244290
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Interstitial lung disease 2 ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia
CTD ClinVar OMIM
PMID:21506741 PMID:21506748 PMID:23321605 PMID:23583980 PMID:23692170 PMID:23695349 PMID:23940607 PMID:24033266 PMID:25741868 PMID:25926289 PMID:28492532 PMID:30345907 More...
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
G
MUC5B-AS1
MUC5B antisense RNA 1
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:24033266 PMID:25741868
NCBI chr11:1,242,261...1,249,676
Ensembl chr11:1,242,261...1,249,676
G
NKD2
NKD inhibitor of WNT signaling pathway 2
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:1,008,802...1,038,943
Ensembl chr 5:1,008,802...1,038,943
G
NKX2-1
NK2 homeobox 1
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:25741868 PMID:28492532
NCBI chr14:36,516,397...36,520,232
Ensembl chr14:36,516,392...36,521,149
G
NKX2-1-AS1
NKX2-1 antisense RNA 1
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:25741868
NCBI chr14:36,519,278...36,523,016
Ensembl chr14:36,519,278...36,523,016
G
NTRK2
neurotrophic receptor tyrosine kinase 2
IEP
mRNA:increased expression:lung
RGD
PMID:21330466
RGD:5684550
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
PARN
poly(A)-specific ribonuclease
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25848748
NCBI chr16:14,435,701...14,630,260
Ensembl chr16:14,435,700...14,632,728
G
PARP1
poly(ADP-ribose) polymerase 1
IEP
mRNA,protein:increased expression, increased activity:fibroblast
RGD
PMID:23260200
RGD:10413908
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PDCD6
programmed cell death 6
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:271,646...314,974
Ensembl chr 5:271,621...314,974
G
PLAU
plasminogen activator, urokinase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:18491991
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PTGS2
prostaglandin-endoperoxide synthase 2
IAGP IEP IDA
DNA:SNPs: :3050G>C, 8473C>T (human) protein:decreased expression:lung:
RGD
PMID:21319594 PMID:14511257 PMID:20203246
RGD:5135280 , RGD:5135507 , RGD:5135461
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
RTEL1
regulator of telomere elongation helicase 1
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Interstitial lung disease 2 ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia
CTD ClinVar
PMID:16199547 PMID:23329068 PMID:23453664 PMID:23959892 PMID:24009516 PMID:24033266 PMID:25047097 PMID:25099625 PMID:25607374 PMID:25620558 PMID:25741868 PMID:25848748 PMID:26025130 PMID:28099038 PMID:28492532 PMID:29344583 PMID:36655009 PMID:37392813 More...
NCBI chr20:63,657,810...63,696,253
Ensembl chr20:63,657,810...63,696,253
G
RTEL1-TNFRSF6B
RTEL1-TNFRSF6B readthrough (NMD candidate)
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2 ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia
ClinVar
PMID:16199547 PMID:23329068 PMID:23453664 PMID:23959892 PMID:24009516 PMID:24033266 PMID:25047097 PMID:25099625 PMID:25607374 PMID:25620558 PMID:25741868 PMID:26025130 PMID:28099038 PMID:28492532 PMID:29344583 PMID:36655009 PMID:37392813 More...
NCBI chr20:63,657,810...63,698,698
Ensembl chr20:63,659,300...63,698,684
G
RTKN2
rhotekin 2
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr10:62,183,900...62,268,844
Ensembl chr10:62,183,035...62,268,844
G
SDHA
succinate dehydrogenase complex flavoprotein subunit A
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:218,320...268,746
Ensembl chr 5:218,303...257,082
G
SETD2
SET domain containing 2, histone lysine methyltransferase
exacerbates
IAGP
associated with lung squamous cell carcinoma; DNA:mutations:multiple (human)
RGD
PMID:33533494
RGD:150429642
NCBI chr 3:47,016,436...47,164,840
Ensembl chr 3:47,016,428...47,164,113
G
SFTA3
surfactant associated 3
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:25741868 PMID:28492532
NCBI chr14:36,473,288...36,519,556
Ensembl chr14:36,473,288...36,513,829 Ensembl chr14:36,473,288...36,513,829
G
SFTPA1
surfactant protein A1
IAGP
ClinVar Annotator: match by term: Pulmonary fibrosis, idiopathic, susceptibility to ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:13680361 PMID:24033266 PMID:25741868
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SFTPA2
surfactant protein A2
IAGP EXP
ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Interstitial lung disease 2 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:16292672 PMID:17580966 PMID:19100526 PMID:20466729 PMID:22853774 PMID:23056344 PMID:24033266 PMID:25553246 PMID:25741868 PMID:28492532 PMID:32855221 More...
NCBI chr10:79,555,852...79,560,407
Ensembl chr10:79,555,852...79,560,407
G
SFTPC
surfactant protein C
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia ClinVar Annotator: match by term: Interstitial lung disease 2 ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Interstitial lung disease 2
CTD ClinVar
PMID:14735158 PMID:15039969 PMID:15516475 PMID:15709974 PMID:18383112 PMID:19443464 PMID:19910179 PMID:22308375 PMID:23025826 PMID:23775869 PMID:24033266 PMID:24081995 PMID:24347114 PMID:25657025 PMID:25741868 PMID:25782673 PMID:27362365 PMID:28492532 PMID:33526882 More...
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
G
SLC12A7
solute carrier family 12 member 7
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:1,050,384...1,155,899
Ensembl chr 5:1,050,384...1,112,063
G
SLC6A18
solute carrier family 6 member 18
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:1,225,381...1,246,189
Ensembl chr 5:1,225,381...1,246,189
G
SLC6A19
solute carrier family 6 member 19
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:1,201,595...1,225,111
Ensembl chr 5:1,201,595...1,225,111
G
SLC9A3
solute carrier family 9 member A3
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:470,456...524,449
Ensembl chr 5:470,456...524,449
G
SMAD2
SMAD family member 2
IEP
mRNA:increased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
G
SMAD6
SMAD family member 6
IEP
mRNA:decreased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr15:66,702,236...66,782,849
Ensembl chr15:66,702,236...66,782,849
G
ST14
ST14 transmembrane serine protease matriptase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26599507
NCBI chr11:130,159,782...130,210,362
Ensembl chr11:130,159,782...130,210,362
G
STAT3
signal transducer and activator of transcription 3
IEP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30481203 PMID:22684844
RGD:6892915
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STN1
STN1 subunit of CST complex
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23583980
NCBI chr10:103,877,569...103,918,184
Ensembl chr10:103,856,806...103,918,332
G
TERC
telomerase RNA component
IAGP EXP
ClinVar Annotator: match by term: Interstitial lung disease 2 CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:17392301 PMID:17460043 PMID:23535734
NCBI chr 3:169,764,610...169,765,060
Ensembl chr 3:169,764,610...169,765,047 Ensembl chr 3:169,764,610...169,765,047
G
TERT
telomerase reverse transcriptase
IAGP EXP
DNA:deletion, missense mutations, splice-site mutations:multiple ClinVar Annotator: match by term: Idiopathic Pulmonary Fibrosis ClinVar Annotator: match by term: Idiopathic Pulmonary Fibrosis | ClinVar Annotator: match by term: Idiopathic fibrosing alveolitis, chronic form | ClinVar Annotator: match by term: Interstitial lung disease 2 ClinVar Annotator: match by term: Idiopathic Pulmonary Fibrosis | ClinVar Annotator: match by term: Interstitial lung disease 2 CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:9536098 PMID:12629597 PMID:15814878 PMID:15885610 PMID:16199547 PMID:16247010 PMID:17392301 PMID:17460043 PMID:17576681 PMID:18302718 PMID:18460650 PMID:18635888 PMID:19489057 PMID:19561322 PMID:19674077 PMID:19760749 PMID:20022961 PMID:20044353 PMID:20301779 PMID:20502709 PMID:20858879 PMID:21436073 PMID:21520174 PMID:22364217 PMID:22424236 PMID:22853774 PMID:22863003 PMID:23535734 PMID:23538340 PMID:23583980 PMID:23716176 PMID:23901009 PMID:24033266 PMID:24833766 PMID:25271372 PMID:25365545 PMID:25741868 PMID:25785092 PMID:26024875 PMID:26136524 PMID:26365799 PMID:27192671 PMID:27540018 PMID:27848944 PMID:28102861 PMID:28104920 PMID:28154186 PMID:28492532 PMID:28495683 PMID:28677271 PMID:28813500 PMID:29036293 PMID:29483670 PMID:30203795 PMID:30426156 PMID:30523342 PMID:31268371 PMID:34019641 PMID:34890115 PMID:35776903 PMID:17392301 More...
RGD:11038666
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TFPI
tissue factor pathway inhibitor
severity
IEP
protein:increased expression:Bronchoalveolar lavage,epithelial cell:
RGD
PMID:10946084
RGD:11060143
NCBI chr 2:187,464,230...187,554,435
Ensembl chr 2:187,464,230...187,565,760
G
THBD
thrombomodulin
severity
IEP
RGD
PMID:20418386
RGD:5685036
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:8473757
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TOLLIP
toll interacting protein
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr11:1,274,371...1,309,632
Ensembl chr11:1,274,371...1,309,654
G
TPPP
tubulin polymerization promoting protein
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:659,862...700,727
Ensembl chr 5:659,862...693,352
G
TRIP13
thyroid hormone receptor interactor 13
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:892,884...919,348
Ensembl chr 5:892,884...919,357
G
WNT5A
Wnt family member 5A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28726637
NCBI chr 3:55,465,715...55,505,263
Ensembl chr 3:55,465,715...55,490,539
G
ZDHHC11
zinc finger DHHC-type containing 11
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:795,605...860,563
Ensembl chr 5:795,605...858,973
G
ZDHHC11B
zinc finger DHHC-type containing 11B
IAGP
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 5:710,355...784,729
Ensembl chr 5:710,355...784,729
G
ATM
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:31509427
RGD:126779564
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102
G
BTK
Bruton tyrosine kinase
ameliorates
ISO
Associated with Acute Lung Injury
RGD
PMID:29516781
RGD:124713566
NCBI chr X:101,349,450...101,390,796
Ensembl chr X:101,349,338...101,390,796
G
DUOX1
dual oxidase 1
IEP
protein:decreased expression:blood plasma (human)
RGD
PMID:24888898
RGD:40903071
NCBI chr15:45,129,994...45,165,574
Ensembl chr15:45,129,933...45,165,576
G
DUOX2
dual oxidase 2
severity
ISO
RGD
PMID:28936773 PMID:25751630 PMID:29556357
RGD:40924644 , RGD:40925925 , RGD:40925921
NCBI chr15:45,092,650...45,114,172
Ensembl chr15:45,092,650...45,114,172
G
FAM157A
family with sequence similarity 157 member A
IEP
protein:increased expression:blood plasma (human)
RGD
PMID:24888898
RGD:40903071
NCBI chr 3:198,153,206...198,222,513
Ensembl chr 3:198,180,755...198,190,365
G
IFIH1
interferon induced with helicase C domain 1
ISO
mRNA:increased expression:nasal cavity mucosa (mouse)
RGD
PMID:25751630
RGD:40925925
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
G
IL21
interleukin 21
ISO
RGD
PMID:25251568
RGD:127285548
NCBI chr 4:122,610,108...122,621,066
Ensembl chr 4:122,610,108...122,621,066
G
IL27
interleukin 27
IEP
protein:increased expression:blood serum (human)
RGD
PMID:22343630
RGD:126790513
NCBI chr16:28,499,362...28,506,834
Ensembl chr16:28,499,362...28,512,051
G
IL32
interleukin 32
IEP
protein:increased expression:blood serum (human)
RGD
PMID:22277801 PMID:19291698 PMID:18414668
RGD:150340718 , RGD:150340751 , RGD:150340729
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
KIR3DS1
killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1
exacerbates
IAGP
DNA:deletion: (human)
RGD
PMID:22652695
RGD:150340578
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:26241898
RGD:11055126
NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833
G
MAPK8
mitogen-activated protein kinase 8
ameliorates
ISO
RGD
PMID:22514650
RGD:150340681
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MARCO
macrophage receptor with collagenous structure
ameliorates
ISO
RGD
PMID:21562316
RGD:41412197
NCBI chr 2:118,942,194...118,994,660
Ensembl chr 2:118,942,194...118,994,660
G
MAVS
mitochondrial antiviral signaling protein
disease_progression
ISO
RGD
PMID:27438481
RGD:40903047
NCBI chr20:3,846,834...3,876,118
Ensembl chr20:3,846,799...3,876,123
G
MIR146A
microRNA 146a
exacerbates ameliorates
ISO
RGD
PMID:31638222 PMID:30611999
RGD:126925152 , RGD:126925153
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
G
MX1
MX dynamin like GTPase 1
ameliorates
ISO IMP
fused with PTD 9-arginine sequence human gene in a mouse model
RGD
PMID:30696001 PMID:31653718 PMID:1371172 PMID:30945621
RGD:126777671 , RGD:126777680 , RGD:126777676 , RGD:126777673
NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
G
PLAC8
placenta associated 8
ISO
RGD
PMID:32639988
RGD:40925929
NCBI chr 4:83,090,048...83,114,729
Ensembl chr 4:83,090,048...83,137,075
G
PPIA
peptidylprolyl isomerase A
ameliorates
IMP
human gene in a mouse model
RGD
PMID:27354005
RGD:150429624
NCBI chr 7:44,796,681...44,803,117
Ensembl chr 7:44,796,680...44,824,564
G
RIGI
RNA sensor RIG-I
ISO
mRNA:increased expression:nasal cavity mucosa (mouse)
RGD
PMID:25751630
RGD:40925925
NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,208
G
RIPK3
receptor interacting serine/threonine kinase 3
exacerbates susceptibility
ISO
RGD
PMID:27321907 PMID:32200799 PMID:28410401
RGD:127229911 , RGD:127229922 , RGD:127229918
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
G
SAA1
serum amyloid A1
IEP
protein:increased expression:blood plasma (human)
RGD
PMID:24888898
RGD:40903071
NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977
G
STAT2
signal transducer and activator of transcription 2
exacerbates
ISO
RGD
PMID:30337919
RGD:41789626
NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,203
G
AGER
advanced glycosylation end-product specific receptor
ISO
RGD
PMID:21423669
RGD:5508765
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
CCL2
C-C motif chemokine ligand 2
severity
ISO
RGD
PMID:11160230
RGD:11528533
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL20
C-C motif chemokine ligand 20
ISO
protein:increased expression:lung
RGD
PMID:20926800
RGD:7483599
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCR6
C-C motif chemokine receptor 6
disease_progression
ISO
RGD
PMID:17379855
RGD:7483617
NCBI chr 6:167,111,795...167,139,141
Ensembl chr 6:167,111,807...167,139,141
G
CXCR3
C-X-C motif chemokine receptor 3
IEP
RGD
PMID:17298426
RGD:5135501
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
CYBB
cytochrome b-245 beta chain
ISO
RGD
PMID:24054721
RGD:10450528
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
treatment
IAGP
DNA:polymorphisms:cds:
RGD
PMID:26861072
RGD:124713410
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
ELANE
elastase, neutrophil expressed
ISO
RGD
PMID:24054721
RGD:10450528
NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247
G
IL17A
interleukin 17A
severity
ISO
RGD
PMID:21807912
RGD:8698654
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
MBL2
mannose binding lectin 2
IAGP
DNA:SNP:exon:rs5030737(human)
RGD
PMID:17311505
RGD:8693758
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
PTX3
pentraxin 3
severity
IAGP IEP
DNA:SNPs, missense mutation:intron, cds:rs2305619, rs1840680, rs3816527 protein:increased expression:bronchoalveolar lavage fluid (human)
RGD
PMID:30275011 PMID:28487045
RGD:38501097 , RGD:38508892
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
G
S100B
S100 calcium binding protein B
ISO
RGD
PMID:21423669
RGD:5508765
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
TLR2
toll like receptor 2
ISO
RGD
PMID:16113258
RGD:8553022
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
susceptibility
IAGP
DNA:polymorphism:exon:p.D299G(human)
RGD
PMID:18275280
RGD:5130863
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO
RGD
PMID:12917249
RGD:11528529
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CD209
CD209 molecule
susceptibility
IAGP
DNA:SNPs:3'utr,intron:multiple
RGD
PMID:22384201
RGD:39938996
NCBI chr19:7,739,993...7,747,534
Ensembl chr19:7,739,993...7,747,564
G
FGF2
fibroblast growth factor 2
treatment
IDA
RGD
PMID:23303813
RGD:8655596
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
IL1A
interleukin 1 alpha
IAGP
DNA:polymorphism, haplotype:promoter:-889C>T (human)
RGD
PMID:18484169
RGD:4142867
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
IAGP
DNA:polymorphism, haplotype: :-511C>T (human)
RGD
PMID:18484169
RGD:4142867
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
ISO
protein:increased expression:respiratory system fluid/secretion, serum
RGD
PMID:24360996
RGD:40903005
NCBI chr 3:52,812,962...52,830,672
Ensembl chr 3:52,812,962...52,830,688
G
MBL2
mannose binding lectin 2
treatment
IDA
RGD
PMID:17335555
RGD:8693746
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
PTX3
pentraxin 3
susceptibility no_association
IAGP IEP
DNA:SNP:intron:rs1840680 (human) protein:increased expression:bronchoalveolar lavage fluid, plasma (human) protein:increased expression:plasma DNA:SNP, missense mutation:intron, cds:rs2305619, rs3816527
RGD
PMID:29020397 PMID:29964232 PMID:29020397 PMID:29020397
RGD:38501098 , RGD:38508894 , RGD:38501098 , RGD:38501098
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
G
VEGFA
vascular endothelial growth factor A
treatment
IDA
RGD
PMID:23303813
RGD:8655596
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
RGD
PMID:11207292
RGD:38549344
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
IL23A
interleukin 23 subunit alpha
severity
ISO
RGD
PMID:16157683
RGD:39457940
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
G
IRAK3
interleukin 1 receptor associated kinase 3
severity
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:22729155 PMID:20864681
RGD:35316077 , RGD:36049798
NCBI chr12:66,189,214...66,254,622
Ensembl chr12:66,189,195...66,254,622
G
LCN2
lipocalin 2
exacerbates ameliorates
ISO
protein:increased expression:lung protein:increased expression:serum
RGD
PMID:29633303 PMID:19342674 PMID:19342674 PMID:19342674 PMID:25234944 PMID:25234944 More...
RGD:126725082 , RGD:126725085 , RGD:126725085 , RGD:126725085 , RGD:126725084 , RGD:126725084
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
PLAC8
placenta associated 8
severity
ISO
RGD
PMID:17404296
RGD:40924563
NCBI chr 4:83,090,048...83,114,729
Ensembl chr 4:83,090,048...83,137,075
G
TREM1
triggering receptor expressed on myeloid cells 1
disease_progression
ISO
RGD
PMID:24396044
RGD:126925976
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
ADA
adenosine deaminase
IEP
protein:increased expression:serum
RGD
PMID:9255891
RGD:5128857
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:16113250
RGD:4891897
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL2
C-X-C motif chemokine ligand 2
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL5
C-X-C motif chemokine ligand 5
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:11254553
RGD:5135252
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
G
IFNG
interferon gamma
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:11349020
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL18
interleukin 18
ISO
RGD
PMID:11083766
RGD:4889865
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
MBL2
mannose binding lectin 2
susceptibility
IEP
RGD
PMID:19073229
RGD:12910934
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
NOD1
nucleotide binding oligomerization domain containing 1
ISO
RGD
PMID:20685341
RGD:5131443
NCBI chr 7:30,424,527...30,478,784
Ensembl chr 7:30,424,527...30,478,784
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
RGD
PMID:20685341
RGD:5131443
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
TLR5
toll like receptor 5
susceptibility
IAGP EXP ISO
DNA:nonsense mutation:cds:p.R392X (human) ClinVar Annotator: match by term: Legionnaire disease, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD RGD
PMID:14623910 PMID:16027372 PMID:23447684 PMID:25741868 PMID:14623910 PMID:17982089 More...
RGD:5129477 , RGD:5129510
NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,248
G
TLR9
toll like receptor 9
ISO
RGD
PMID:18426877
RGD:5130707
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
RGD
PMID:18838275
RGD:5131445
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
RGD
PMID:18838275
RGD:5131445
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
ADA
adenosine deaminase
IEP
protein:increased expression:serum
RGD
PMID:9255891
RGD:5128857
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
ATP1B2
ATPase Na+/K+ transporting subunit beta 2
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr17:7,646,627...7,657,770
Ensembl chr17:7,646,627...7,657,770
G
CCL4
C-C motif chemokine ligand 4
ISO
RGD
PMID:16988274
RGD:4892091
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:lung, secretion (mouse)
RGD
PMID:18717637
RGD:4891914
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCL8
C-C motif chemokine ligand 8
ISO
RGD
PMID:16988274
RGD:4892091
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
G
CCR5
C-C motif chemokine receptor 5
ISO
protein:increased expression:lung, T-helper cell (mouse)
RGD
PMID:16988274
RGD:4892091
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CLEC5A
C-type lectin domain containing 5A
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr 7:141,927,357...141,946,974
Ensembl chr 7:141,927,357...141,947,007
G
COL3A1
collagen type III alpha 1 chain
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
G
COL6A1
collagen type VI alpha 1 chain
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr21:45,981,770...46,005,048
Ensembl chr21:45,981,770...46,005,050
G
COL6A2
collagen type VI alpha 2 chain
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848
G
CRP
C-reactive protein
IEP
RGD
PMID:21426633
RGD:5131292
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
DNASE1L3
deoxyribonuclease 1L3
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr 3:58,192,257...58,210,972
Ensembl chr 3:58,192,257...58,214,697
G
FCER2
Fc epsilon receptor II
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr19:7,688,776...7,702,131
Ensembl chr19:7,688,758...7,702,146
G
FLT1
fms related receptor tyrosine kinase 1
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
G
GALC
galactosylceramidase
IEP ISO
associated with Guillain-Barre syndrome; protein:increased expression:serum (human) associated with Guillain-Barre syndrome; protein:increased expression:Cerebrospinal fluid, serum (human) protein:increased expression:serum (mouse)
RGD
PMID:27490360 PMID:29301655 PMID:30396892 PMID:30396892 PMID:12225900
RGD:38599168 , RGD:38599172 , RGD:38599171 , RGD:38599171 , RGD:38599169
NCBI chr14:87,933,014...87,993,667
Ensembl chr14:87,837,820...87,993,665
G
HDC
histidine decarboxylase
ISO
RGD
PMID:17158962
RGD:5143920
NCBI chr15:50,241,947...50,265,726
Ensembl chr15:50,241,947...50,265,965
G
HTRA3
HtrA serine peptidase 3
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr 4:8,269,754...8,307,098
Ensembl chr 4:8,269,754...8,307,098
G
IFNG
interferon gamma
ISO
mRNA:increased expression:lung:
RGD
PMID:7935058
RGD:10755754
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL13
interleukin 13
IEP
protein:increased expression:serum
RGD
PMID:20416219
RGD:4145765
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL22RA2
interleukin 22 receptor subunit alpha 2
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr 6:137,143,820...137,173,644
Ensembl chr 6:137,143,820...137,173,648
G
INHBA
inhibin subunit beta A
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
G
KLRF1
killer cell lectin like receptor F1
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr12:9,800,052...9,845,005
Ensembl chr12:9,827,481...9,845,007
G
MS4A1
membrane spanning 4-domains A1
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr11:60,455,847...60,470,752
Ensembl chr11:60,455,846...60,470,752
G
PLD4
phospholipase D family member 4
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr14:104,924,879...104,937,785
Ensembl chr14:104,924,713...104,937,761
G
SPIB
Spi-B transcription factor
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr19:50,418,938...50,431,314
Ensembl chr19:50,418,938...50,431,314
G
TCF7
transcription factor 7
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr 5:134,108,218...134,148,210
Ensembl chr 5:134,114,681...134,151,865
G
TCL1A
TCL1 family AKT coactivator A
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr14:95,709,947...95,714,125
Ensembl chr14:95,709,947...95,714,196
G
TNF
tumor necrosis factor
IEP
protein:increased expression:serum
RGD
PMID:20416219
RGD:4145765
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF13C
TNF receptor superfamily member 13C
severity
HEP
RGD
PMID:28302172
RGD:32716376
NCBI chr22:41,922,032...41,926,806
Ensembl chr22:41,922,032...41,926,806
G
PTCH1
patched 1
IEP
mRNA:decreased expression:epithelium of nasopharynx
RGD
PMID:23001130
RGD:150523839
NCBI chr 9:95,442,980...95,516,971
Ensembl chr 9:95,442,980...95,517,057
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
IEP
protein:decreased expression:serum
RGD
PMID:19725899
RGD:5686851
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ALB
albumin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19389874
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
IEP
protein:increased expression:nasal turbinate
RGD
PMID:19364335
RGD:5147461
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
G
CAT
catalase
IEP
protein:decreased expression:plasma
RGD
PMID:20493834
RGD:5130771
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL2
C-C motif chemokine ligand 2
IEP
protein:increased expression:nasal turbinate, mucosa (human)
RGD
PMID:9865755
RGD:8548839
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCR2
C-C motif chemokine receptor 2
IEP
mRNA:increased expression:Nasal Mucosa
RGD
PMID:17982926
RGD:4145109
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR5
C-C motif chemokine receptor 5
IEP
mRNA:increased expression:nasal mucosa (human)
RGD
PMID:17982926
RGD:4145109
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CD40
CD40 molecule
ISO
RGD
PMID:20226305
RGD:5132269
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD86
CD86 molecule
IEP
protein:increased expression:nasal mucosa, dendritic cell (human)
RGD
PMID:17088138
RGD:4892343
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CHIA
chitinase acidic
IEP
mRNA, protein:increased expression:turbinate, mucosa (human)
RGD
PMID:20422678
RGD:5037226
NCBI chr 1:111,290,851...111,320,563
Ensembl chr 1:111,290,851...111,320,566
G
EGR1
early growth response 1
IAGP
DNA:snp:5' utr:g.-4071A>G rs7729723 (human)
RGD
PMID:19833116
RGD:5131984
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
F2RL1
F2R like trypsin receptor 1
IEP
RGD
PMID:17727088
RGD:4892590
NCBI chr 5:76,819,030...76,835,315
Ensembl chr 5:76,818,933...76,835,315
G
GSTP1
glutathione S-transferase pi 1
susceptibility
IAGP
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:17181111
RGD:4142523
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
HMOX1
heme oxygenase 1
IEP
mRNA, protein:increased expression: nasal mucosa
RGD
PMID:16540907
RGD:4145406
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
ICAM1
intercellular adhesion molecule 1
ISO IEP
protein:increased expression:lung, endothelium (mouse) protein:increased secretion:nasopharynx (human)
RGD
PMID:19968652 PMID:19047814
RGD:4145464 , RGD:4145520
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNGR1
interferon gamma receptor 1
IAGP
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
G
IL13
interleukin 13
IEP
mRNA, protein:increased expression:nasal mucosa
RGD
PMID:8520776
RGD:4782826
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL17A
interleukin 17A
severity
IEP
protein:increased expression:serum
RGD
PMID:19226302
RGD:4889151
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
susceptibility
IAGP
DNA:SNP:promoter:c. -607A>C (rs1946518) (human)
RGD
PMID:16406079
RGD:4889924
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
IAGP
DNA:polymorphism:exon:c.4845G>T (human)
RGD
PMID:14533660
RGD:4142859
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1R1
interleukin 1 receptor type 1
IDA
RGD
PMID:18637763
RGD:5037238
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
G
IL2
interleukin 2
IEP
protein:decreased expression:serum:
RGD
PMID:17608155
RGD:8662959
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL4
interleukin 4
treatment
IEP
protein:increased expression:serum
RGD
PMID:21171297 PMID:9237816 PMID:15329007
RGD:5128559 , RGD:7829817 , RGD:7829804
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL5
interleukin 5
IEP
protein: increased levels: sputum
RGD
PMID:22186238
RGD:5687140
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
MMP2
matrix metallopeptidase 2
IEP
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
IEP
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:nasal mucosa
RGD
PMID:14587983
RGD:4892078
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
IAGP
DNA:snp:promoter:g.-786T>C (human)
RGD
PMID:18086269
RGD:4892054
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NR3C1
nuclear receptor subfamily 3 group C member 1
IEP
protein:altered expression:nasal mucosa
RGD
PMID:20185258
RGD:4892593
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
PPARG
peroxisome proliferator activated receptor gamma
IEP
mRNA, protein:increased expression:nasal mucosa (human)
RGD
PMID:17116814
RGD:8552811
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PTGS1
prostaglandin-endoperoxide synthase 1
IEP
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
TBXA2R
thromboxane A2 receptor
treatment
IMP
RGD
PMID:15247523
RGD:11059532
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
G
PLAU
plasminogen activator, urokinase
IDA
Gene product used in treatment of disease
RGD
PMID:20304453
RGD:4891955
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
TNC
tenascin C
IEP
protein:increased expression:pleura
RGD
PMID:10950882
RGD:4889594
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TREM1
triggering receptor expressed on myeloid cells 1
treatment
ISO
RGD
PMID:20819512
RGD:127284851
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
ADA
adenosine deaminase
IEP IDA
protein:increased activity:pleural fluid: protein:increased activity:serum: protein:increased expression:serum:
RGD
PMID:21860532 PMID:1818842 PMID:1689629 PMID:18357489
RGD:152995280 , RGD:152998934 , RGD:152995292 , RGD:152995288
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
ADA2
adenosine deaminase 2
treatment
IEP
RGD
PMID:8656037
RGD:152995258
NCBI chr22:17,178,790...17,221,848
Ensembl chr22:17,178,790...17,258,235
G
CCL22
C-C motif chemokine ligand 22
IEP
RGD
PMID:20337996
RGD:4891473
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
G
CCR2
C-C motif chemokine receptor 2
IDA
RGD
PMID:19159432
RGD:4145106
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR5
C-C motif chemokine receptor 5
IEP
protein:increased expression:pleural fluid, natural killer cell (human)
RGD
PMID:19159432
RGD:4145106
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
FOXP3
forkhead box P3
disease_progression
IEP
associated with human immunodeficiency virus infectious disease;
RGD
PMID:21303360
RGD:36947878
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
IL1B
interleukin 1 beta
IAGP
DNA:polymorphism: :3953T>C (human)
RGD
PMID:10377182
RGD:4143226
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
IAGP
DNA:repeat (human)
RGD
PMID:10377182
RGD:4143226
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL27
interleukin 27
exacerbates
IEP
associated with Pleural Effusion;protein:increased expression:pleural fluid (human) protein:increased expression:alveolar system (human)
RGD
PMID:25753767 PMID:31819557 PMID:23962500 PMID:28844060
RGD:126790505 , RGD:126790549 , RGD:126790523 , RGD:126790517
NCBI chr16:28,499,362...28,506,834
Ensembl chr16:28,499,362...28,512,051
G
IL33
interleukin 33
IEP
protein:increased expression:pleural fluid:
RGD
PMID:23301222
RGD:39939042
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
MMP9
matrix metallopeptidase 9
IEP
protein:increased expression:pleura:
RGD
PMID:18715875
RGD:5129700
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
TLR4
toll like receptor 4
IEP
RGD
PMID:18295348
RGD:4144193
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNC
tenascin C
IEP
protein:increased expression:pleura
RGD
PMID:10950882
RGD:4889594
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
ADA
adenosine deaminase
ISO
RGD
PMID:16860713
RGD:5128847
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
ALOX5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:9109363
RGD:4890429
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
ANXA1
annexin A1
ISO
RGD
PMID:15784654
RGD:2306907
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393
G
BDKRB1
bradykinin receptor B1
ISO
RGD
PMID:11853231
RGD:5129218
NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
G
BDKRB2
bradykinin receptor B2
ISO
RGD
PMID:15316088 PMID:9208140
RGD:4891029 , RGD:4891041
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
C3
complement C3
ISO
protein:increased activity:pleural cavity
RGD
PMID:18256172
RGD:5129520
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CAT
catalase
ISO
RGD
PMID:19778612
RGD:5130749
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL11
C-C motif chemokine ligand 11
ISO
protein:increased expression:pleural fluid
RGD
PMID:11877329 PMID:11564646
RGD:4145443 , RGD:4145479
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL25
C-C motif chemokine ligand 25
ISO
protein:increased expression:pleural fluid
RGD
PMID:18056919
RGD:5130924
NCBI chr19:8,052,341...8,062,650
Ensembl chr19:8,052,318...8,062,660
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:lung (mouse)
RGD
PMID:18672096
RGD:4890016
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCR3
C-C motif chemokine receptor 3
ISO
associated with Mycobacterium Infections
RGD
PMID:17158890
RGD:4145643
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CSF3
colony stimulating factor 3
IDA
RGD
PMID:8841835
RGD:11039424
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
RGD
PMID:14527170
RGD:5135449
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
RGD
PMID:14527170
RGD:5135449
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL2
C-X-C motif chemokine ligand 2
ISO
RGD
PMID:21549112 PMID:14527170
RGD:5135064 , RGD:5135449
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
RGD
PMID:14527170
RGD:5135449
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
EDNRA
endothelin receptor type A
ISO
RGD
PMID:15107459
RGD:4892325
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
G
ELANE
elastase, neutrophil expressed
ISO
RGD
PMID:20860667
RGD:10450565
NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247
G
ESR1
estrogen receptor 1
ISO
RGD
PMID:17035596
RGD:4892303
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
ICAM1
intercellular adhesion molecule 1
IEP EXP ISO
associated with Tuberculosis; protein:increased expression:pleural fluid, natural killer cell (human) CTD Direct Evidence: marker/mechanism protein:increased expression:bronchial epithelium (mouse)
CTD RGD
PMID:11181422 PMID:19714575 PMID:19056932
RGD:4145510 , RGD:4145519
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IL10
interleukin 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11181422
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL15
interleukin 15
IDA
RGD
PMID:10823416
RGD:4990464
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL17A
interleukin 17A
treatment
ISO
RGD
PMID:21898269
RGD:7175307
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1B
interleukin 1 beta
ISO EXP
CTD Direct Evidence: marker/mechanism protein:increased expression:pleural cavity, exudate (rat) protein:increased expression:lung
CTD RGD
PMID:11181422 PMID:20141620 PMID:21898269 PMID:20175894
RGD:4142808 , RGD:7175307 , RGD:4142826
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
IDA
RGD
PMID:8491511
RGD:4143233
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL6
interleukin 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11181422
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
MPO
myeloperoxidase
ISO
protein:increased activity:lung
RGD
PMID:11577999
RGD:5130991
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
RGD
PMID:14673141
RGD:6893408
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:pleural cavity (rat)
RGD
PMID:21898269 PMID:20141620
RGD:7175307 , RGD:4142808
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PLA2G6
phospholipase A2 group VI
ISO
RGD
PMID:15003994
RGD:6482741
NCBI chr22:38,111,495...38,181,830
Ensembl chr22:38,111,495...38,214,778
G
PTAFR
platelet activating factor receptor
treatment
ISO
RGD
PMID:8395390
RGD:10043147
NCBI chr 1:28,147,166...28,193,856
Ensembl chr 1:28,147,166...28,193,936
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:20141620 PMID:15740981
RGD:4142808 , RGD:5143929
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
SELP
selectin P
ISO EXP
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11181422 PMID:21147071
RGD:6219005
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SERPINE1
serpin family E member 1
susceptibility
IAGP
associated with Familial Mediterranean Fever;DNA: DNA:polymorphism:promoter:rs1799768 (human):
RGD
PMID:23052617
RGD:13207414
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
TNF
tumor necrosis factor
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11181422 PMID:15380531 PMID:11161459 PMID:20141620
RGD:4143474 , RGD:4142808
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFSF8
TNF superfamily member 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15380531
NCBI chr 9:114,893,343...114,930,595
Ensembl chr 9:114,893,343...114,930,595
G
ALOX5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:12773506
RGD:4890419
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
AICDA
activation induced cytidine deaminase
ISO
RGD
PMID:26456931
RGD:11098923
NCBI chr12:8,602,170...8,612,859
Ensembl chr12:8,602,155...8,613,242
G
ALOX5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:20231413
RGD:4890435
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
BTK
Bruton tyrosine kinase
ameliorates
ISO
RGD
PMID:30646846
RGD:124715470
NCBI chr X:101,349,450...101,390,796
Ensembl chr X:101,349,338...101,390,796
G
C3
complement C3
disease_progression
ISO IEP
associated with Liver Cirrhosis, Experimental;protein:decreased expression:respiratory system fluid/secretion protein:decreased expression:serum
RGD
PMID:17956621 PMID:15972516 PMID:20405
RGD:5129523 , RGD:5129509 , RGD:5130163
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C5
complement C5
severity
ISO
RGD
PMID:7814608
RGD:5130159
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
CCL5
C-C motif chemokine ligand 5
susceptibility
ISO
RGD
PMID:16455992
RGD:4892130
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CD14
CD14 molecule
ISO
RGD
PMID:17185649
RGD:4144788
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CHI3L1
chitinase 3 like 1
IEP
protein:increased secretion:serum (human)
RGD
PMID:10515841
RGD:4892626
NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
G
CRHR1
corticotropin releasing hormone receptor 1
ISO
RGD
PMID:21774994
RGD:5147472
NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,277...45,835,828
G
CRHR2
corticotropin releasing hormone receptor 2
ISO
RGD
PMID:21774994
RGD:5147472
NCBI chr 7:30,651,942...30,700,103
Ensembl chr 7:30,651,942...30,700,129
G
CRP
C-reactive protein
disease_progression
IEP
RGD
PMID:21281676
RGD:5131293
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:20958976
RGD:5134957
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL8
C-X-C motif chemokine ligand 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
protein:increased expression:lung
RGD
PMID:20381636
RGD:5135285
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
DEFB4A
defensin beta 4A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716 Ensembl chr 8:7,894,677...7,896,716
G
HMOX1
heme oxygenase 1
ISO
associated with influenza;protein:increased expression:lung
RGD
PMID:17348295
RGD:4145366
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HP
haptoglobin
IEP
RGD
PMID:19396720
RGD:5147385
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
IL15
interleukin 15
ISO
protein:increased expression:alveolar macrophage, bronchial epithelial cell
RGD
PMID:17611121
RGD:5000755
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL15RA
interleukin 15 receptor subunit alpha
ISO
RGD
PMID:17611121
RGD:5000755
NCBI chr10:5,948,900...5,978,741
Ensembl chr10:5,943,639...5,978,187
G
IL17A
interleukin 17A
ISO
RGD
PMID:19995896
RGD:4888531
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
ISO
RGD
PMID:15770015
RGD:4889960
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL6
interleukin 6
ISO
RGD
PMID:20643849
RGD:4143255
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
LEP
leptin
ISO
RGD
PMID:17822444
RGD:5128869
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LEPR
leptin receptor
ISO
RGD
PMID:21148797
RGD:5128846
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
MAPK1
mitogen-activated protein kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MASP2
MBL associated serine protease 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12904520
NCBI chr 1:11,026,523...11,047,239
Ensembl chr 1:11,022,009...11,047,239
G
MBL2
mannose binding lectin 2
no_association
IAGP
DNA:polymorphisms:5' utr, exon:multiple (human) DNA:mutations:5' utr, exon:multiple (human)
RGD
PMID:12047967 PMID:18641104
RGD:4889478 , RGD:4889477
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:17056580
RGD:4891950
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PTEN
phosphatase and tensin homolog
ameliorates
ISO
myeloid knockout
RGD
PMID:20505137
RGD:127285597
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
SFTPD
surfactant protein D
severity
ISO
RGD
PMID:16255775
RGD:4143519
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
SIRT1
sirtuin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
STING1
stimulator of interferon response cGAMP interactor 1
ISO
RGD
PMID:29263110
RGD:39128230
NCBI chr 5:139,475,533...139,482,758
Ensembl chr 5:139,475,533...139,482,935
G
TLR2
toll like receptor 2
ISO
RGD
PMID:19956717
RGD:4145321
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TNF
tumor necrosis factor
ISO
associated with influenza;protein:increased expression:lung
RGD
PMID:9032201 PMID:17348295
RGD:4143479 , RGD:4145366
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TREM1
triggering receptor expressed on myeloid cells 1
ameliorates
ISO
RGD
PMID:24752755 PMID:19596984
RGD:126928121 , RGD:127229903
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
AZIN1
antizyme inhibitor 1
ISO
mRNA:increased expression:alveolar macrophage
RGD
PMID:19158080
RGD:14700806
NCBI chr 8:102,826,302...102,864,200
Ensembl chr 8:102,826,111...102,893,864
G
C3
complement C3
ISO
RGD
PMID:17169032
RGD:5129525
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CCL2
C-C motif chemokine ligand 2
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:20618689
RGD:4891428
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:10968950
RGD:8547797
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CSF2
colony stimulating factor 2
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19487471
RGD:5131475
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
ISO
RGD
PMID:20377877
RGD:4144112
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
IL23A
interleukin 23 subunit alpha
ISO
RGD
PMID:17403873
RGD:39458043
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
G
IL33
interleukin 33
treatment
ISO
RGD
PMID:21220696
RGD:40400892
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
MUC1
mucin 1, cell surface associated
IEP
protein:increased expression:serum
RGD
PMID:9617869
RGD:5131424
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
NOS2
nitric oxide synthase 2
ISO
protein:decreased dimerization:alveolar macrophage mRNA:increased expression:alveolar macrophage
RGD
PMID:20558778 PMID:20377877
RGD:4891486 , RGD:4144112
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
SFTPA1
surfactant protein A1
ISO
protein:increased expression:lung
RGD
PMID:11385364
RGD:4143431
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SFTPB
surfactant protein B
ISO
protein:decreased expression:lung
RGD
PMID:11385364
RGD:4143431
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
G
SFTPC
surfactant protein C
ISO
protein:decreased expression:lung
RGD
PMID:11385364
RGD:4143431
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
G
SFTPD
surfactant protein D
ISO
protein:increased expression:lung
RGD
PMID:11385364
RGD:4143431
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
TLR2
toll like receptor 2
ISO
RGD
PMID:18400546
RGD:4145341
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
ABCF1
ATP binding cassette subfamily F member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 6:30,571,442...30,591,522
Ensembl chr 6:30,571,393...30,597,179
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
severity
IAGP
DNA:polymorphism:cds:allele A (human)
RGD
PMID:4375858
RGD:39938844
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
G
ACE
angiotensin I converting enzyme
disease_progression
IEP IMP
associated with Hypertension
RGD
PMID:17727310 PMID:20051911 PMID:19455553
RGD:4140922 , RGD:4140916 , RGD:4140918
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ADORA1
adenosine A1 receptor
ISO
RGD
PMID:15630442
RGD:5129098
NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
G
ADORA2A
adenosine A2a receptor
ISO
associated with Lung Injury associated with Anemia, Sickle Cell
RGD
PMID:18703794 PMID:17601796 PMID:20798237
RGD:4890364 , RGD:4890376 , RGD:4890358
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
ADRB2
adrenoceptor beta 2
ISO
RGD
PMID:19925785
RGD:4145041
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
G
AGT
angiotensinogen
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:28960804
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AHR
aryl hydrocarbon receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23337360
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
ALB
albumin
disease_progression
IEP
RGD
PMID:23286966
RGD:11035283
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
BDKRB2
bradykinin receptor B2
ISO
RGD
PMID:15021973
RGD:4891030
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
C3
complement C3
ISO
RGD
PMID:10886251
RGD:5129562
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C3AR1
complement C3a receptor 1
ISO
associated with Respiratory Syncytial Virus Infections
RGD
PMID:17079327
RGD:5129688
NCBI chr12:8,056,844...8,066,359
Ensembl chr12:8,056,844...8,066,359
G
C5
complement C5
IDA ISO
associated with Respiratory Syncytial Virus Infections
RGD
PMID:3631740 PMID:17079327
RGD:5130161 , RGD:5129688
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
CASP1
caspase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CCL11
C-C motif chemokine ligand 11
ISO EXP
mRNA, protein:increased expression:lung, respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:11290805 PMID:10595930
RGD:4145445 , RGD:4145450
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL13
C-C motif chemokine ligand 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr17:34,356,480...34,358,610
Ensembl chr17:34,356,480...34,358,610
G
CCL17
C-C motif chemokine ligand 17
ISO EXP
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:15993846
RGD:2306304
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
G
CCL19
C-C motif chemokine ligand 19
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
G
CCL2
C-C motif chemokine ligand 2
ISO EXP
protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:19648283
RGD:4891461
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL20
C-C motif chemokine ligand 20
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCL22
C-C motif chemokine ligand 22
ISO
mRNA:increased expression:lung
RGD
PMID:15993846
RGD:2306304
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
G
CCL23
C-C motif chemokine ligand 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr17:36,013,058...36,017,972
Ensembl chr17:36,013,056...36,017,972
G
CCL24
C-C motif chemokine ligand 24
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 7:75,810,825...75,823,372
Ensembl chr 7:75,810,825...75,823,356
G
CCL3
C-C motif chemokine ligand 3
HEP
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL4
C-C motif chemokine ligand 4
EXP HEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human)
CTD RGD
PMID:21625544 PMID:32407669
RGD:30296672
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCL7
C-C motif chemokine ligand 7
IEP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:15191918
RGD:5130985
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
CCL8
C-C motif chemokine ligand 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
G
CCR1
C-C motif chemokine receptor 1
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:20870892
RGD:5688175
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CCR2
C-C motif chemokine receptor 2
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:14615370 PMID:17284325
RGD:4145068 , RGD:8661704
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR3
C-C motif chemokine receptor 3
ISO
mRNA:increased expression:lung
RGD
PMID:19762220
RGD:4145622
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CCR5
C-C motif chemokine receptor 5
ISO
Idiopathic Pneumonia Syndrome; mRNA:increased expression:lung (mouse)
RGD
PMID:15546955
RGD:4892103
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CCR6
C-C motif chemokine receptor 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 6:167,111,795...167,139,141
Ensembl chr 6:167,111,807...167,139,141
G
CCR7
C-C motif chemokine receptor 7
IEP
mRNA, protein:increased expression:lung
RGD
PMID:16394278
RGD:5130919
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472
G
CCR9
C-C motif chemokine receptor 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 3:45,886,064...45,903,174
Ensembl chr 3:45,884,425...45,903,174
G
CD14
CD14 molecule
IEP
protein:increased expression:multiple
RGD
PMID:20302606
RGD:4144794
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD163
CD163 molecule
IEP
associated with liver disease;protein:increased expression:blood serum (human)
RGD
PMID:26339412
RGD:11251207
NCBI chr12:7,470,811...7,503,777
Ensembl chr12:7,470,811...7,503,893
G
CD40LG
CD40 ligand
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CRHR2
corticotropin releasing hormone receptor 2
ISO
RGD
PMID:16855006
RGD:5130933
NCBI chr 7:30,651,942...30,700,103
Ensembl chr 7:30,651,942...30,700,129
G
CRP
C-reactive protein
disease_progression severity
IEP
RGD
PMID:21439658 PMID:21258955
RGD:5131291 , RGD:5131283
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CSF2
colony stimulating factor 2
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11732872 PMID:19633061
RGD:4142837
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CSF3R
colony stimulating factor 3 receptor
HEP
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 1:36,466,043...36,483,314
Ensembl chr 1:36,466,043...36,483,278
G
CSK
C-terminal Src kinase
ISO
RGD
PMID:14975240
RGD:5134363
NCBI chr15:74,782,080...74,803,197
Ensembl chr15:74,782,080...74,803,197
G
CX3CL1
C-X3-C motif chemokine ligand 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
CXCL1
C-X-C motif chemokine ligand 1
ISO EXP
mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:20728373
RGD:5134959
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung
RGD
PMID:15265940 PMID:14979941
RGD:5135445 , RGD:5135491
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL2
C-X-C motif chemokine ligand 2
ISO
mRNA, protein:increased expression:lung mRNA:increased expression:lung
RGD
PMID:20728373 PMID:18367723
RGD:5134959 , RGD:5135235
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL5
C-X-C motif chemokine ligand 5
IEP EXP
protein:increased expression:sputum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:18410262
RGD:5135259
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
mRNA:increased expression:lung
RGD
PMID:20650015
RGD:4892029
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCL8
C-X-C motif chemokine ligand 8
ISO HEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human)
CTD RGD
PMID:21625544 PMID:32407669
RGD:30296672
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCL9
C-X-C motif chemokine ligand 9
IEP EXP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:17052299 PMID:15265940
RGD:5135440 , RGD:5135445
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
CXCR2
C-X-C motif chemokine receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
G
CXCR3
C-X-C motif chemokine receptor 3
ISO EXP
CTD Direct Evidence: marker/mechanism associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung
CTD RGD
PMID:21625544 PMID:15265940 PMID:14979941
RGD:5135445 , RGD:5135491
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
susceptibility
IAGP
DNA:polymorphism (human)
RGD
PMID:15928955
RGD:4142512
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO IAGP
protein:increased expression:alveolus, epithelial cell DNA:polymorphism (human)
RGD
PMID:14698565 PMID:15928955
RGD:4892223 , RGD:4142512
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
DEFB1
defensin beta 1
IEP
protein:increased expression:serum
RGD
PMID:17000097
RGD:4892262
NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936
G
EDN1
endothelin 1
severity
IEP
protein:increased secretion:plasma (human)
RGD
PMID:20529344
RGD:4144879
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EGF
epidermal growth factor
resistance
ISO
RGD
PMID:21701422
RGD:6906904
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
G
EGR1
early growth response 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29787794
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
FCGR3A
Fc gamma receptor IIIa
treatment
IAGP
associated with Hodgkin Disease;DNA:SNP:exon:p.F158V (rs396991) (human)
RGD
PMID:20423913
RGD:11352258
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
GRP
gastrin releasing peptide
IEP
protein:increased expression:serum (human)
RGD
PMID:30146822
RGD:401700396
NCBI chr18:59,219,189...59,230,771
Ensembl chr18:59,220,158...59,230,774
G
HDC
histidine decarboxylase
ISO
RGD
PMID:14556983
RGD:5143922
NCBI chr15:50,241,947...50,265,726
Ensembl chr15:50,241,947...50,265,965
G
HMOX1
heme oxygenase 1
susceptibility
IAGP EXP
DNA:allele:promoter:L allele of the (GT)n repeat (>30 repeats) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16582079 PMID:16582079
RGD:1601608
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
associated with Reperfusion Injury
RGD
PMID:22882462
RGD:8547727
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNAR1
interferon alpha and beta receptor subunit 1
resistance
ISO
Cryptococcus (yeast) pneumonia
RGD
PMID:18566423 PMID:18566423
RGD:5490275 , RGD:5490275
NCBI chr21:33,324,395...33,359,864
Ensembl chr21:33,324,387...33,359,864
G
IFNG
interferon gamma
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31095431 PMID:20080200
RGD:7495767
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
G
IL10
interleukin 10
disease_progression
IEP
protein:increased expression:blood
RGD
PMID:20595152
RGD:4140400
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL13
interleukin 13
IEP EXP
associated with Respiratory Distress Syndrome, Newborn; protein:increased expression:bronchoalveolar lavage fluid CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:19695190
RGD:4145774
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL13RA2
interleukin 13 receptor subunit alpha 2
IEP
mRNA:increased expression:lung, fibroblast
RGD
PMID:15161635
RGD:4890021
NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977
G
IL17A
interleukin 17A
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:20498020 PMID:22848348
RGD:4888524 , RGD:9068417
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
ISO EXP IEP
CTD Direct Evidence: marker/mechanism associated with reperfusion injury mRNA, protein:increased expression:lung,bronchoalveolar fluid protein:increased expression:serum
CTD RGD
PMID:21625544 PMID:17400729 PMID:16052682 PMID:11739527 PMID:15955140
RGD:4889590 , RGD:4889825 , RGD:729357 , RGD:4889836
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
ISO
mRNA:increased expression:lung
RGD
PMID:8806881
RGD:7794765
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
IEP HEP EXP ISO
protein:increased expression:lung mRNA:increased expression:bronchoalveolar lavage (human) CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung mRNA, protein:increased expression:lung
CTD RGD
PMID:21625544 PMID:19825784 PMID:32407669 PMID:20476872 PMID:19901996 PMID:20155581 PMID:20007584 More...
RGD:4142831 , RGD:30296672 , RGD:4142536 , RGD:4143211 , RGD:4142827 , RGD:4142812
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1R1
interleukin 1 receptor type 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
G
IL1R2
interleukin 1 receptor type 2
EXP HEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human)
CTD RGD
PMID:21625544 PMID:32407669
RGD:30296672
NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544
G
IL1RN
interleukin 1 receptor antagonist
no_association disease_progression
IAGP HEP ISO IDA
DNA:polymorphism (human) mRNA:increased expression:bronchoalveolar lavage (human) mRNA:increased expression:bronchioalveolar lavage fluid, neutrophil (rat) mRNA:increased expression:lung DNA:polymorphism:intron (human)
RGD
PMID:19900796 PMID:32407669 PMID:1385928 PMID:16369129 PMID:17569781 PMID:18838927 More...
RGD:4143204 , RGD:30296672 , RGD:8551846 , RGD:4143213 , RGD:4142871 , RGD:4142865
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL27
interleukin 27
ISO
RGD
PMID:19124731
RGD:5128483
NCBI chr16:28,499,362...28,506,834
Ensembl chr16:28,499,362...28,512,051
G
IL2RB
interleukin 2 receptor subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,118,666...37,175,118
G
IL32
interleukin 32
IEP
mRNA:increased expression:peripheral blood mononuclear cell, blood plasma (human)
RGD
PMID:32860786
RGD:150340740
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
IL33
interleukin 33
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24453940
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
IL4
interleukin 4
EXP HEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human)
CTD RGD
PMID:21625544 PMID:32407669
RGD:30296672
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4R
interleukin 4 receptor
HEP
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL5RA
interleukin 5 receptor subunit alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 3:3,066,324...3,110,374
Ensembl chr 3:3,066,324...3,126,613
G
IL6
interleukin 6
disease_progression
IEP EXP
protein:increased expression:blood CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:20595152
RGD:4140400
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6ST
interleukin 6 cytokine family signal transducer
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022
G
IRF5
interferon regulatory factor 5
severity
IEP
RGD
PMID:29847542
RGD:40907064
NCBI chr 7:128,937,032...128,950,038
Ensembl chr 7:128,937,457...128,950,038
G
ITGA2
integrin subunit alpha 2
treatment
ISO
RGD
PMID:11207307
RGD:8693217
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITGA4
integrin subunit alpha 4
treatment
ISO
RGD
PMID:8703473
RGD:9698424
NCBI chr 2:181,457,205...181,538,940
Ensembl chr 2:181,457,202...181,538,940
G
ITGB2
integrin subunit beta 2
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:10030843
RGD:6482228
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
G
ITGB3
integrin subunit beta 3
disease_progression
ISO
RGD
PMID:12746502
RGD:5100478
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
G
LCN2
lipocalin 2
exacerbates
ISO
associated with Escherichia Coli Infections
RGD
PMID:20633248
RGD:126779583
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
LIAS
lipoic acid synthetase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:32017981
NCBI chr 4:39,459,056...39,479,506
Ensembl chr 4:39,459,004...39,485,109
G
MBL2
mannose binding lectin 2
IEP
protein:increased secretion:lung (human) protein:increased expression:Bronchoalveolar lavage:
RGD
PMID:18988662 PMID:15249448
RGD:4889459 , RGD:8693755
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MIF
macrophage migration inhibitory factor
severity
IAGP
DNA:repeats:promoter
RGD
PMID:19346297
RGD:4891058
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MIR150
microRNA 150
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29205062
NCBI chr19:49,500,785...49,500,868
Ensembl chr19:49,500,785...49,500,868
G
MIR20A
microRNA 20a
IEP
RGD
PMID:29115456
RGD:25823151
NCBI chr13:91,351,065...91,351,135
Ensembl chr13:91,351,065...91,351,135
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:18007984
RGD:5130157
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MUC1
mucin 1, cell surface associated
IEP
protein:increased expression:serum
RGD
PMID:11802251
RGD:5131281
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MUC2
mucin 2, oligomeric mucus/gel-forming
treatment
ISO
RGD
PMID:23590300
RGD:7349359
NCBI chr11:1,074,874...1,110,508
Ensembl chr11:1,074,875...1,110,511
G
MYD88
MYD88 innate immune signal transduction adaptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26882889
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
G
MYLK
myosin light chain kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15863634
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
G
NFKBIA
NFKB inhibitor alpha
susceptibility
IAGP
associated with combined immunodeficiency;DNA:missense mutation:CDS:c.106T>G (p.S36A) (human)
RGD
PMID:31683054
RGD:126925985
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NRP1
neuropilin 1
treatment
ISO
RGD
PMID:36373992
RGD:401901166
NCBI chr10:33,177,493...33,334,667
Ensembl chr10:33,177,492...33,336,262
G
PARP1
poly(ADP-ribose) polymerase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20561897
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PF4
platelet factor 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 4:73,980,811...73,982,124
Ensembl chr 4:73,980,811...73,982,027
G
POMC
proopiomelanocortin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:6254450
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
REG3A
regenerating family member 3 alpha
ISO
RGD
PMID:12579542
RGD:9831426
NCBI chr 2:79,157,006...79,159,753
Ensembl chr 2:79,157,003...79,159,753
G
SERPINE1
serpin family E member 1
disease_progression
IEP IAGP
Pneumonia, Ventilator-Associated; protein:increased expression:Bronchoalveolar Lavage Fluid DNA:polymorphism:promoter:
RGD
PMID:20473240 PMID:19387177
RGD:4143511 , RGD:4143525
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SFTPA1
surfactant protein A1
ISO IEP
protein:decreased expression:lung
RGD
PMID:15967375 PMID:8542113
RGD:4143394 , RGD:4143452
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SFTPB
surfactant protein B
ISO IMP
RGD
PMID:12594064 PMID:16024721 PMID:15967375
RGD:4143412 , RGD:4143393 , RGD:4143394
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
G
SFTPC
surfactant protein C
ISO
RGD
PMID:15967375
RGD:4143394
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
G
SFTPD
surfactant protein D
ISO IMP IEP
associated with Bronchitis;protein:decreased expression:lung
RGD
PMID:15967375 PMID:17925426 PMID:18266831
RGD:4143394 , RGD:4143504 , RGD:4143517
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
SIRT1
sirtuin 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:24633890
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SLC11A2
solute carrier family 11 member 2
ISO
RGD
PMID:21278260
RGD:5688709
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
SOD3
superoxide dismutase 3
IDA
RGD
PMID:16842247
RGD:1581268
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
G
SPP1
secreted phosphoprotein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
TGFB1
transforming growth factor beta 1
severity
IEP EXP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:lung
CTD RGD
PMID:21625544 PMID:19181604 PMID:19965809
RGD:4145141 , RGD:4145120
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TLR2
toll like receptor 2
susceptibility
ISO
RGD
PMID:19011150
RGD:4145330
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26882889 PMID:20357263
RGD:4142858
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNC
tenascin C
IEP
protein:increased expression:serum, respiratory system fluid/secretion
RGD
PMID:19721293
RGD:4889573
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21625544 PMID:28917655 PMID:34390737
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF1A
TNF receptor superfamily member 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFRSF1B
TNF receptor superfamily member 1B
susceptibility
IDA EXP IAGP
Idiopathic Pneumonia Syndrome CTD Direct Evidence: marker/mechanism associated with Carcinoma, Non-Small-Cell Lung; DNA:snp:cds:p.M196R rs1061622 (human)
CTD RGD
PMID:21625544 PMID:18664626 PMID:20811626
RGD:5131448 , RGD:5131286
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
TNFSF12
TNF superfamily member 12
HEP
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr17:7,549,058...7,557,881
Ensembl chr17:7,548,508...7,557,890
G
VDR
vitamin D receptor
susceptibility
ISO IAGP
DNA:SNP: :rs2239185(human)
RGD
PMID:17224129 PMID:25367052
RGD:4889851 , RGD:11074745
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
GC
GC vitamin D binding protein
IEP
protein:increased expression:bronchoalveolar fluid:
RGD
PMID:21136918
RGD:5509873
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
IDO1
indoleamine 2,3-dioxygenase 1
ISO
RGD
PMID:20385761
RGD:39938865
NCBI chr 8:39,913,891...39,928,790
Ensembl chr 8:39,902,275...39,928,790
G
PTX3
pentraxin 3
IEP
protein:increased expression:bronchoalveolar lavage fluid, plasma (human)
RGD
PMID:29964232
RGD:38508894
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
G
ABCB1
ATP binding cassette subfamily B member 1
treatment
IAGP
DNA:SNP: :2677G>A (human)
RGD
PMID:26067842
RGD:11098541
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ADA
adenosine deaminase
IEP
protein:increased expression:plasma, respiratory system fluid/secretion protein:increased activity:blood, pulmonary alveolar duct protein:increased activity:sputum:
RGD
PMID:12194640 PMID:2212911 PMID:19460251
RGD:5128854 , RGD:152995390 , RGD:152995271
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
ADA2
adenosine deaminase 2
IEP
protein:increased activity:sputum:
RGD
PMID:19460251
RGD:152995271
NCBI chr22:17,178,790...17,221,848
Ensembl chr22:17,178,790...17,258,235
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
IEP
protein:increased expression:plasma
RGD
PMID:22022605
RGD:5686405
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
AKT1
AKT serine/threonine kinase 1
susceptibility
IAGP
DNA:SNP,haplotype:intron: IVS3+18 C/C (human)
RGD
PMID:20141546
RGD:38676498
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALOX5
arachidonate 5-lipoxygenase
susceptibility
IAGP
DNA:polymorphism, repeat:promoter, exon:g.760G>A (human)
RGD
PMID:18174194
RGD:4890411
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
ASAP1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25774636
NCBI chr 8:130,052,104...130,443,674
Ensembl chr 8:130,052,104...130,443,674
G
ATF3
activating transcription factor 3
IEP
mRNA,protein:increased expression:lung
RGD
PMID:20856677
RGD:34888225
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
C3
complement C3
IEP
RGD
PMID:19472039
RGD:5129500
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CCL1
C-C motif chemokine ligand 1
susceptibility
ISO IAGP
mRNA:increased expression:lung, dendritic cell DNA:SNP: :multiple (human)
RGD
PMID:18703681 PMID:19057661
RGD:4891409 , RGD:4891408
NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
G
CCL19
C-C motif chemokine ligand 19
ISO
mRNA:increased expression:lung
RGD
PMID:19933855
RGD:5130906
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
G
CCL2
C-C motif chemokine ligand 2
susceptibility
IAGP EXP
DNA:polymorphism: :-2518A>G (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16352737 PMID:18940815 PMID:20111728
RGD:4891439
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL5
C-C motif chemokine ligand 5
susceptibility
IAGP IEP
DNA:snps:5' utr:g.-403G>A rs2280788, g.-28C>G rs2107538 (human) mRNA:increased expression:lung (human)
RGD
PMID:19335954 PMID:15128813
RGD:4891879 , RGD:4892112
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCR2
C-C motif chemokine receptor 2
disease_progression
ISO
RGD
PMID:11438742
RGD:734715
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR5
C-C motif chemokine receptor 5
IEP
protein:decreased expression:blood, T cell (human)
RGD
PMID:16379602
RGD:4892094
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CD14
CD14 molecule
susceptibility
IEP IAGP
protein:increased expression:monocyte, serum DNA:polymorphism:promoter:c. -159C>T (human)
RGD
PMID:18008256 PMID:18008256
RGD:4144205 , RGD:4144205
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD163
CD163 molecule
exacerbates
IEP
protein:increased expression:blood plasma, CD14-positive monocyte (human) protein:increased expression:blood serum (human)
RGD
PMID:27685837 PMID:27684274
RGD:127285801 , RGD:127345136
NCBI chr12:7,470,811...7,503,777
Ensembl chr12:7,470,811...7,503,893
G
CD1D
CD1d molecule
susceptibility
IAGP
DNA:SNPS, haplotype:intron, enhancer: (rs859009,rs859010, rs973742) (human)
RGD
PMID:30972222
RGD:127345096
NCBI chr 1:158,178,030...158,186,427
Ensembl chr 1:158,178,030...158,186,427
G
CD209
CD209 molecule
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism associated with HIV Seropositivity; DNA:SNP:promoter: -336A>G (rs4804803) (human) DNA:SNPs:promoter:-139G>A, -336A>G, -871A>G (rs2287886,rs4804803,rs735239) (human)
CTD RGD
PMID:16379498 PMID:19126442 PMID:24874302
RGD:39939062 , RGD:39938981
NCBI chr19:7,739,993...7,747,534
Ensembl chr19:7,739,993...7,747,564
G
CD274
CD274 molecule
IEP
protein:increased expression:Tcell, B cell, monocyte
RGD
PMID:23661793
RGD:40818418
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
CD36
CD36 molecule (CD36 blood group)
susceptibility
IAGP
DNA:SNPs: :rs1194182, rs10499859(human)
RGD
PMID:28693442
RGD:41412192
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD86
CD86 molecule
IEP
protein:decreased expression:sputum, macrophage (human)
RGD
PMID:17713660
RGD:4892339
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CLEC4M
C-type lectin domain family 4 member M
susceptibility
ISO IAGP
DNA:repeats:exon 4: allele 4, allele 5, allele 9 (human)
RGD
PMID:19770268 PMID:24874302 PMID:17224292
RGD:39938983 , RGD:39938981 , RGD:39938987
NCBI chr19:7,763,243...7,769,605
Ensembl chr19:7,763,210...7,769,605
G
CRP
C-reactive protein
severity
IEP
associated with HIV Infections
RGD
PMID:21219690 PMID:21197091
RGD:5131284 , RGD:5131287
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CXCL10
C-X-C motif chemokine ligand 10
treatment
IEP
RGD
PMID:29843631
RGD:27095956
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL2
C-X-C motif chemokine ligand 2
disease_progression
ISO
RGD
PMID:20454613
RGD:5135037
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL5
C-X-C motif chemokine ligand 5
susceptibility
ISO
mRNA:increased expression:lung
RGD
PMID:16790804
RGD:5135246
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL6
C-X-C motif chemokine ligand 6
susceptibility
ISO
mRNA:increased expression:lung
RGD
PMID:16790804
RGD:5135246
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCL8
C-X-C motif chemokine ligand 8
exacerbates
IEP HEP
protein:increased expression:serum (human) RNA:increased expression:blood plasma (human)
RGD
PMID:16001981 PMID:27434276
RGD:39939055 , RGD:150523784
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYBA
cytochrome b-245 alpha chain
no_association
IAGP
DNA:SNPs:exons:214C>T (rs4673), 521C>T (rs17845095) (human)
RGD
PMID:16608528
RGD:4780358
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
G
DDIT3
DNA damage inducible transcript 3
IEP
mRNA,protein:increased expression:lung
RGD
PMID:20856677
RGD:34888225
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
EGFR
epidermal growth factor receptor
disease_progression
IAGP
associated with lung adenocarcinoma;
RGD
PMID:29621876 PMID:22173705
RGD:38599162 , RGD:38599176
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EREG
epiregulin
susceptibility
IAGP
DNA:SNP:exon 4: (rs2367707) (human)
RGD
PMID:30634928
RGD:39457687
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
G
FOXP3
forkhead box P3
susceptibility
IAGP
DNA:polymorphism:promoter:-924A>G(human)
RGD
PMID:29020928
RGD:38501101
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
GBE1
1,4-alpha-glucan branching enzyme 1
IAGP
DNA:SNP:intron:rs2307058 (human)
RGD
PMID:28355295
RGD:18337291
NCBI chr 3:81,489,703...81,761,645
Ensembl chr 3:81,489,703...81,761,645
G
GSTM1
glutathione S-transferase mu 1
susceptibility
IAGP
associated with GSTT1 null deletion; DNA:deletion: :
RGD
PMID:20297661
RGD:4140932
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTT1
glutathione S-transferase theta 1
susceptibility
IAGP
DNA:deletion: :
RGD
PMID:20297661
RGD:4140932
G
HAVCR2
hepatitis A virus cellular receptor 2
IEP
RGD
PMID:21382414
RGD:5135524
NCBI chr 5:157,085,832...157,109,044
Ensembl chr 5:157,085,422...157,142,869
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
IAGP
RGD
PMID:18652916
RGD:5144001
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,990...33,089,696
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
disease_progression susceptibility
IAGP
DNA:polymorphisms (human) DNA:polymorphism: :HLA-DQB1*3:03(human) DNA:polymorphism:cds:HLA-DQB1*0201(human)
RGD
PMID:19230186 PMID:28612994 PMID:24024195
RGD:5147614 , RGD:36049765 , RGD:36049753
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility
IAGP
DNA:polymorphism:cds:HLA-DRB1*0201(human) DNA:polymorphism: :HLA-DRB1*09:01(human)
RGD
PMID:24024195 PMID:28612994
RGD:36049753 , RGD:36049765
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
IDO1
indoleamine 2,3-dioxygenase 1
treatment
IEP
RGD
PMID:32369456
RGD:39939073
NCBI chr 8:39,913,891...39,928,790
Ensembl chr 8:39,902,275...39,928,790
G
IL13
interleukin 13
IEP
mRNA:increased expression:Leukocytes, Mononuclear
RGD
PMID:10608794
RGD:4145649
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL15
interleukin 15
IEP
mRNA, protein:increased expression:lung
RGD
PMID:11742275
RGD:4990461
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL18
interleukin 18
IEP
protein:increased expression:serum
RGD
PMID:15955140
RGD:4889836
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
ISO
RGD
PMID:9176116
RGD:4142835
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
severity susceptibility
IEP IAGP
protein:increased expression:lung DNA:polymorphism: :3953T>C (human) protein:increased expression:bronchioalveolar lavage fluid (human)
RGD
PMID:10543265 PMID:16634865 PMID:10631206
RGD:4143180 , RGD:5147843 , RGD:4143179
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
ISO
RGD
PMID:28128217
RGD:39938965
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL1RN
interleukin 1 receptor antagonist
severity
IEP IDA
protein:increased expression:lung, serum
RGD
PMID:10543265 PMID:14619382 PMID:10631206
RGD:4143180 , RGD:4143174 , RGD:4143179
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL23A
interleukin 23 subunit alpha
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:16002675 PMID:21156751 PMID:20624887 PMID:11801672
RGD:39457949 , RGD:39458038 , RGD:39458036 , RGD:39457953
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
G
IL27
interleukin 27
exacerbates
IAGP
DNA:SNPs:promoter, exon:-964A>G, 2905T>G (human) DNA:SNPs:promoter,exons:-964A>G, 2905T>G, 4730T>C (rs153109, rs17855750, rs181206) (human)
RGD
PMID:31949807 PMID:30948177
RGD:126790508 , RGD:39456132
NCBI chr16:28,499,362...28,506,834
Ensembl chr16:28,499,362...28,512,051
G
IL27RA
interleukin 27 receptor subunit alpha
ISO
RGD
PMID:15749890
RGD:5128486
NCBI chr19:14,031,762...14,053,218
Ensembl chr19:14,031,762...14,053,218
G
IL32
interleukin 32
treatment
IEP
RGD
PMID:31378983
RGD:150340743
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
IL33
interleukin 33
ISO
RGD
PMID:28128217
RGD:39938965
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
IL4
interleukin 4
severity
ISO
RGD
PMID:20832364
RGD:5128550
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4R
interleukin 4 receptor
IEP
protein:decreased expression:serum
RGD
PMID:21251883
RGD:5128510
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
IEP
RGD
PMID:20624776
RGD:4143257
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6R
interleukin 6 receptor
IEP
protein:decreased expression:T cell
RGD
PMID:20019339
RGD:5128632
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
IRF1
interferon regulatory factor 1
ISO
RGD
PMID:11083808
RGD:5128719
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
IEP
protein:increased expression:urine
RGD
PMID:29636444
RGD:40903003
NCBI chr 3:52,812,962...52,830,672
Ensembl chr 3:52,812,962...52,830,688
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
IDA
protein:decreased phosphorylation:macrophage, nucleus
RGD
PMID:19737230
RGD:4889999
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KIR3DS1
killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1
susceptibility
IAGP
DNA:deletion:
RGD
PMID:22653583
RGD:150340566
G
LCN2
lipocalin 2
exacerbates disease_progression
ISO
RGD
PMID:19050270 PMID:30534124
RGD:126779558 , RGD:126779565
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
LTA
lymphotoxin alpha
susceptibility
IAGP
DNA:polymorphism:intron:252G>A (human)
RGD
PMID:20180006
RGD:4143234
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
G
MARCO
macrophage receptor with collagenous structure
susceptibility
IAGP
DNA:SNP: :rs12998782(human) DNA:SNPs:introns:rs4491733,rs12998782,rs13389814,rs7559955 (human) DNA:SNPs: :rs2278589, rs6751745,rs6748401 (human)
RGD
PMID:28693442 PMID:23617307 PMID:27853145
RGD:41412192 , RGD:41412195 , RGD:41412194
NCBI chr 2:118,942,194...118,994,660
Ensembl chr 2:118,942,194...118,994,660
G
MBL2
mannose binding lectin 2
IAGP
DNA:polymorphisms:5' utr, exon:multiple (human)
RGD
PMID:19199550
RGD:4889452
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MIF
macrophage migration inhibitory factor
susceptibility
IAGP
DNA:SNP: :rs755622 (human)
RGD
PMID:20439102
RGD:4891004
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MIR30A
microRNA 30a
disease_progression
IEP
RGD
PMID:25866116
RGD:35668864
NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621
G
MMP3
matrix metallopeptidase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24890593
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MMP7
matrix metallopeptidase 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24890593
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
G
MMP8
matrix metallopeptidase 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24890593
NCBI chr11:102,711,796...102,724,954
Ensembl chr11:102,711,796...102,727,050
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:16982845
RGD:5130746
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
NAT2
N-acetyltransferase 2
susceptibility
IAGP
RGD
PMID:20297661
RGD:4140932
NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
G
NFKBIA
NFKB inhibitor alpha
IEP
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:9379002
RGD:126908014
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NOD2
nucleotide binding oligomerization domain containing 2
susceptibility
IAGP
DNA:SNPs:CDs:p.P268S, R702W, A725G (human)
RGD
PMID:18419343
RGD:5131510
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
NOS2
nitric oxide synthase 2
IAGP
DNA:SNPs:multiple (human)
RGD
PMID:19575238
RGD:4144122
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PDCD1
programmed cell death 1
treatment
IEP
protein:increased expression:Tcell, B cell, monocyte
RGD
PMID:23661793 PMID:23661793
RGD:40818418 , RGD:40818418
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
PDCD1LG2
programmed cell death 1 ligand 2
IEP
protein:increased expression:Tcell, B cell, monocyte
RGD
PMID:23661793
RGD:40818418
NCBI chr 9:5,510,531...5,571,282
Ensembl chr 9:5,510,531...5,571,282
G
PLAUR
plasminogen activator, urokinase receptor
severity
IEP
RGD
PMID:18359089
RGD:6483832
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
IAGP
DNA:SNPs:cds:788G>A, 1858C>T (human)
RGD
PMID:19563523
RGD:6484723
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
G
SFTPA1
surfactant protein A1
susceptibility
IAGP
DNA:SNP:intron:1416C>T (human) DNA:SNPs:exons:307G>A, 776C>T (human)
RGD
PMID:12476938 PMID:16292672
RGD:4144875 , RGD:4144874
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SLC11A1
solute carrier family 11 member 1
susceptibility
IAGP
DNA:polymorphism:intron (human) DNA:deletion:3'UTR:
RGD
PMID:21169917 PMID:24024195
RGD:5684974 , RGD:36049753
NCBI chr 2:218,382,273...218,396,894
Ensembl chr 2:218,382,029...218,396,894
G
TAP1
transporter 1, ATP binding cassette subfamily B member
IAGP
associated with HIV Infections;
RGD
PMID:21843574
RGD:6482248
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
TAP2
transporter 2, ATP binding cassette subfamily B member
susceptibility
IAGP
DNA:polymorphism: :
RGD
PMID:9062973
RGD:5147851
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
G
TLR1
toll like receptor 1
IEP
mRNA:increased expression:blood
RGD
PMID:16493059
RGD:4889525
NCBI chr 4:38,787,569...38,805,644
Ensembl chr 4:38,790,677...38,856,817
G
TLR2
toll like receptor 2
susceptibility
IEP IAGP
mRNA, protein:increased expression:blood, T cell DNA:SNP: :rs1816702 (human) DNA:polymorphism:intron (human) DNA:polymorphisms: :multiple (human)
RGD
PMID:19552525 PMID:19723394 PMID:20298136 PMID:20113509
RGD:4145355 , RGD:4145323 , RGD:4145304 , RGD:4145320
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
susceptibility severity
IEP IAGP
protein:increased expression:monocyte DNA:SNP:intron: rs5030729 (human) DNA:polymorphisms:cds: p. D299F, T399I (human)
RGD
PMID:18008256 PMID:19575238 PMID:20403143
RGD:4144205 , RGD:4144122 , RGD:4144106
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR9
toll like receptor 9
IAGP
DNA:snps:multiple (human)
RGD
PMID:19771452
RGD:5130704
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TNF
tumor necrosis factor
disease_progression susceptibility
IDA ISO IAGP
DNA:polymorphisms::c.-857 C>T, c. -863 A>C (human)
RGD
PMID:18212516 PMID:9176116 PMID:20650298
RGD:4143395 , RGD:4142835 , RGD:4143388
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TREM1
triggering receptor expressed on myeloid cells 1
disease_progression
IEP
RGD
PMID:29844416
RGD:126925977
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
VDR
vitamin D receptor
susceptibility
IAGP
DNA:SNPs:5' UTR (human) DNA:SNP (human) DNA:SNPs:promoter, 3' UTR (human) DNA:SNPs (human)
RGD
PMID:18397302 PMID:20231985 PMID:17236578 PMID:18231846 PMID:15295697
RGD:4889842 , RGD:4889830 , RGD:4889849 , RGD:4889845 , RGD:4889853
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
CD274
CD274 molecule
IEP
protein:increased expression: larynx
RGD
PMID:22322668
RGD:40822813
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
FOXP3
forkhead box P3
susceptibility
IAGP
DNA:SNPs:promoter:rs5902434,rs2232365 (human)
RGD
PMID:28298239
RGD:38549360
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
severity
IAGP
DNA:polymorphisms:cds:HLA-DQB1*0201, HLA-DQB1*0602 (human) DNA:polymorphism: :HLA-DQB1*0602(human)
RGD
PMID:15336778 PMID:19861144
RGD:5147657 , RGD:36174013
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
severity
IAGP
DNA:polymorphisms:cds:HLA-DRB1*0301, HLA-DRB1*0102 (human)
RGD
PMID:15336778
RGD:5147657
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
IL32
interleukin 32
IEP
mRNA:decreased expression:blood serum (human)
RGD
PMID:24015634
RGD:150340746
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
KIR2DS1
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
severity
IAGP
RGD
PMID:19861144
RGD:36174013
G
KIR2DS5
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5
severity
IAGP
RGD
PMID:19861144
RGD:36174013
G
KIR3DS1
killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1
severity
IAGP
RGD
PMID:19861144
RGD:36174013
G
NLRP1
NLR family pyrin domain containing 1
IAGP
ClinVar Annotator: match by term: Respiratory papillomatosis, juvenile recurrent, congenital
ClinVar OMIM
PMID:17377159 PMID:24033266 PMID:25741868 PMID:28492532 PMID:31484767
NCBI chr17:5,501,396...5,584,509
Ensembl chr17:5,499,415...5,619,424
G
PDCD1
programmed cell death 1
IEP
RGD
PMID:22322668
RGD:40822813
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
TAP1
transporter 1, ATP binding cassette subfamily B member
severity
IAGP
DNA:polymorphism:cds:p.D637G(human)
RGD
PMID:14976605
RGD:5147844
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
AGR2
anterior gradient 2, protein disulphide isomerase family member
IAGP
ClinVar Annotator: match by term: Respiratory infections, recurrent, and failure to thrive with or without diarrhea
OMIM ClinVar
PMID:25741868 PMID:34952832
NCBI chr 7:16,791,811...16,804,999
Ensembl chr 7:16,791,811...16,833,433
G
ADAM33
ADAM metallopeptidase domain 33
susceptibility
IAGP
DNA:SNPs: :multiple (human)
RGD
PMID:18778489 PMID:15298558
RGD:4145378 , RGD:4145383
NCBI chr20:3,667,975...3,682,010
Ensembl chr20:3,667,965...3,682,246
G
ANG
angiogenin
IEP
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
G
BDKRB1
bradykinin receptor B1
IEP
RGD
PMID:12165532
RGD:5129220
NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
G
BDKRB2
bradykinin receptor B2
IDA IMP
RGD
PMID:1890650 PMID:11149999
RGD:4891044 , RGD:4891033
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
BDNF
brain derived neurotrophic factor
susceptibility
ISO IAGP
mRNA:increased expression:nasal cavity epithelium DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human)
RGD
PMID:20464992 PMID:21723144
RGD:4891116 , RGD:8655967
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
C3
complement C3
ISO IEP
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17345707 PMID:20109314
RGD:5129524 , RGD:5129539
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C3AR1
complement C3a receptor 1
severity
IEP
protein:increased expression:nasal cavity
RGD
PMID:18538384
RGD:5129559
NCBI chr12:8,056,844...8,066,359
Ensembl chr12:8,056,844...8,066,359
G
C5AR1
complement C5a receptor 1
IEP
RGD
PMID:18538384
RGD:5129559
NCBI chr19:47,307,477...47,322,066
Ensembl chr19:47,290,023...47,322,066
G
CASP1
caspase 1
IEP ISO
protein:increased expression:serum
RGD
PMID:12396474 PMID:20974310
RGD:5130192 , RGD:5130187
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CAT
catalase
treatment
ISO
protein:increased activity:blood,nasal cavity mucosa:
RGD
PMID:21541033
RGD:9479054
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL1
C-C motif chemokine ligand 1
IEP
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17982926
RGD:4145109
NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
G
CCL11
C-C motif chemokine ligand 11
severity
IEP ISO
associated with Sinusitis;protein:increased expression:paranasal sinus protein:increased expression:nasal mucus mRNA:increased expression:lung, nose
RGD
PMID:17999785 PMID:16120080 PMID:16765544
RGD:4145455 , RGD:4145411 , RGD:4145462
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL17
C-C motif chemokine ligand 17
IEP
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
G
CCL19
C-C motif chemokine ligand 19
ISO
RGD
PMID:17947663
RGD:5130909
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
G
CCL22
C-C motif chemokine ligand 22
IEP
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
G
CCL24
C-C motif chemokine ligand 24
IEP IAGP
mRNA:increased expression:nasal cavity epithelium DNA:SNPs: :179T>C, 275C>T (human)
RGD
PMID:17982926 PMID:15580493
RGD:4145109 , RGD:4891493
NCBI chr 7:75,810,825...75,823,372
Ensembl chr 7:75,810,825...75,823,356
G
CCL26
C-C motif chemokine ligand 26
IAGP IEP
DNA:polymorphism: :2497T>G (human) associated with Eosinophilia;protein:increased expression:oronasal secretion (human)
RGD
PMID:15580493 PMID:24989688
RGD:4891493 , RGD:11531119
NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896
G
CCL4
C-C motif chemokine ligand 4
IEP
RGD
PMID:19786211
RGD:5130914
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCL7
C-C motif chemokine ligand 7
IEP
RGD
PMID:17982926
RGD:4145109
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
CCL8
C-C motif chemokine ligand 8
IEP
RGD
PMID:20625511
RGD:5131089
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
G
CCR2
C-C motif chemokine receptor 2
susceptibility
IAGP
Rhinitis, Allergic, Seasonal; DNA:SNP:cds:p.V64I (human)
RGD
PMID:17135764
RGD:4145111
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR3
C-C motif chemokine receptor 3
ISO IEP IAGP
mRNA:increased expression:nose protein:increased expression:blood, T cell DNA:SNP:exon:51T>C (human)
RGD
PMID:20696593 PMID:17156343 PMID:17135764
RGD:4145454 , RGD:4145645 , RGD:4145111
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CD14
CD14 molecule
susceptibility resistance
IAGP
DNA:polymorphism:promoter:c. -159c>T (human)
RGD
PMID:20109306 PMID:16950285
RGD:4144795 , RGD:4144810
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD28
CD28 molecule
IEP
RGD
PMID:21356099
RGD:5131612
NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,475...203,738,912
G
CD80
CD80 molecule
ISO
RGD
PMID:21108691
RGD:5132622
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
G
CDC42
cell division cycle 42
IEP
mRNA:increased expression:nasal turbinate
RGD
PMID:19432938
RGD:5688273
NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360
G
CFTR
CF transmembrane conductance regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16083808
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CRHR1
corticotropin releasing hormone receptor 1
IEP
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,277...45,835,828
G
CRHR2
corticotropin releasing hormone receptor 2
IEP
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chr 7:30,651,942...30,700,103
Ensembl chr 7:30,651,942...30,700,129
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
IEP
protein:increased expression:T cell
RGD
PMID:17625281
RGD:4891512
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CX3CL1
C-X3-C motif chemokine ligand 1
IEP
protein:increased expression:plasma
RGD
PMID:14657873
RGD:4891906
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
CXCL6
C-X-C motif chemokine ligand 6
IEP
protein:increased expression:nasal mucus
RGD
PMID:20659080
RGD:4892030
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
IAGP
DNA:SNP:3' utr:*1934G>A (human)
RGD
PMID:20088379
RGD:5143945
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYSLTR1
cysteinyl leukotriene receptor 1
IMP ISO IEP
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:18946234 PMID:15379985 PMID:17627772 PMID:16689996
RGD:4888516 , RGD:4847512 , RGD:4781451 , RGD:4783198
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
G
CYSLTR2
cysteinyl leukotriene receptor 2
IEP
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:16689996
RGD:4783198
NCBI chr13:48,653,929...48,711,226
Ensembl chr13:48,653,711...48,711,226
G
FCER1A
Fc epsilon receptor Ia
IEP
RGD
PMID:20650300
RGD:5128714
NCBI chr 1:159,283,575...159,308,202
Ensembl chr 1:159,289,714...159,308,224
G
FIS1
fission, mitochondrial 1
ISO
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316
G
HDC
histidine decarboxylase
IAGP ISO
DNA:SNP: :p.E644D (rs2073440) (human)
RGD
PMID:20608921 PMID:15054596
RGD:5128884 , RGD:5143921
NCBI chr15:50,241,947...50,265,726
Ensembl chr15:50,241,947...50,265,965
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
IAGP
DNA:polymorphisms:cds:HLA-DQA1*0201, HLA-DQA1*0302 (human)
RGD
PMID:14990915
RGD:5147798
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP
DNA:polymorphism:cds:HLA-DQB1*0602 (human)
RGD
PMID:14990915
RGD:5147798
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HNMT
histamine N-methyltransferase
no_association
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17651147 PMID:17651147
RGD:5128885
NCBI chr 2:137,964,473...138,016,364
Ensembl chr 2:137,964,020...138,016,364
G
HRH1
histamine receptor H1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chr 3:11,137,238...11,263,557
Ensembl chr 3:11,137,093...11,263,557
G
IL13
interleukin 13
disease_progression susceptibility
ISO IAGP
mRNA:increased expression:nose associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human) DNA:polymorphism: :rs1800925 (human)
RGD
PMID:16120094 PMID:20696593 PMID:17088137 PMID:20358028 PMID:20484924
RGD:4206706 , RGD:4145454 , RGD:4159171 , RGD:4145767 , RGD:4145534
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO
RGD
PMID:17088137
RGD:4159171
NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977
G
IL15
interleukin 15
ISO
RGD
PMID:16750998
RGD:5000756
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL16
interleukin 16
IEP ISO
protein:increased expression:serum protein:increased expression:nasal cavity epithelium, serum
RGD
PMID:18254318 PMID:19295235
RGD:5024932 , RGD:5024931
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
G
IL17A
interleukin 17A
IEP IDA
protein:increased expression:nasal mucosa
RGD
PMID:20506642 PMID:19927541
RGD:4889137 , RGD:4889144
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
disease_progression
ISO IEP
protein:increased expression:nasal lavage fluid, bronchoalveolar lavage fluid rhinitis allergic, seasonal; protein:increased expression:plasma protein:increased expression:serum
RGD
PMID:17305282 PMID:15934281 PMID:17323858
RGD:4889917 , RGD:4889927 , RGD:4889916
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1B
interleukin 1 beta
susceptibility
ISO IAGP IEP
mRNA:increased expression:nasal cavity epithelium associated with Hypersensitivity;DNA:polymorphism: :-511C>T (human) associated with Hypersensitivity;protein:increased expression:nasal mucus
RGD
PMID:20490816 PMID:14533660 PMID:10224452
RGD:4142821 , RGD:4142859 , RGD:4143227
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
severity
IEP
associated with Sinusitis;DNA:SNPs: :multiple (human)
RGD
PMID:19671251
RGD:5144228
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL1RN
interleukin 1 receptor antagonist
susceptibility
IEP IAGP
associated with Hypersensitivity;DNA:repeat:intron (human)
RGD
PMID:15178892 PMID:14533660 PMID:10224452
RGD:4143215 , RGD:4142859 , RGD:4143227
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2
interleukin 2
susceptibility
IAGP
DNA:SNP:promoter:rs2069762(human)
RGD
PMID:16333313
RGD:8663473
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL21
interleukin 21
ISO
RGD
PMID:17982108
RGD:5147397
NCBI chr 4:122,610,108...122,621,066
Ensembl chr 4:122,610,108...122,621,066
G
IL22
interleukin 22
severity
IEP
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:21535180
RGD:5147409
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
G
IL23R
interleukin 23 receptor
susceptibility
IAGP
DNA:SNP,haplotype: :rs7517847(human)
RGD
PMID:23696856
RGD:8549605
NCBI chr 1:67,138,637...67,265,903
Ensembl chr 1:67,138,907...67,259,979
G
IL27RA
interleukin 27 receptor subunit alpha
ISO
RGD
PMID:19354069
RGD:5128480
NCBI chr19:14,031,762...14,053,218
Ensembl chr19:14,031,762...14,053,218
G
IL4
interleukin 4
ISO EXP
mRNA:increased expression:nasal cavity epithelium CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:19672097 PMID:21208219 PMID:18826099
RGD:5128558 , RGD:2317285
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4R
interleukin 4 receptor
IAGP
DNA:polymorphism: :c.1432T>C (human)
RGD
PMID:15564773
RGD:4890394
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL5
interleukin 5
ISO
RGD
PMID:11884474
RGD:5128622
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
IL9
interleukin 9
IEP
RGD
PMID:20525149
RGD:5128687
NCBI chr 5:135,892,246...135,895,841
Ensembl chr 5:135,892,246...135,895,841
G
LEP
leptin
IDA
RGD
PMID:19860581
RGD:5128850
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
MBL2
mannose binding lectin 2
susceptibility
IAGP
DNA:polymorphism: :
RGD
PMID:18831943
RGD:8693717
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MFN1
mitofusin 1
ISO
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr 3:179,347,709...179,394,936
Ensembl chr 3:179,347,709...179,394,936
G
MIF
macrophage migration inhibitory factor
severity
IEP ISO
protein:increased expression:serum, nasal mucosa
RGD
PMID:15053202 PMID:15922619
RGD:4891045 , RGD:4891056
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MS4A2
membrane spanning 4-domains A2
IDA
RGD
PMID:15480314
RGD:5131152
NCBI chr11:60,088,259...60,098,467
Ensembl chr11:60,088,261...60,098,467
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
ISO IEP
mRNA:increased expression:nose
RGD
PMID:20696593 PMID:15715404
RGD:4145454 , RGD:7364740
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
NGF
nerve growth factor
IEP
associated with Sinusitis;protein:increased expression:respiratory system mucosa protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19958603 PMID:10224365
RGD:4891064 , RGD:4891115
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NGFR
nerve growth factor receptor
IEP
protein:increased expression:blood, eosinophil
RGD
PMID:18647313
RGD:5144116
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NOD1
nucleotide binding oligomerization domain containing 1
IEP
mRNA:decreased expression:nose
RGD
PMID:20384614
RGD:5131446
NCBI chr 7:30,424,527...30,478,784
Ensembl chr 7:30,424,527...30,478,784
G
NOD2
nucleotide binding oligomerization domain containing 2
susceptibility
IAGP
DNA:polymorphisms:cds:2104C>T,2722G>C (human)
RGD
PMID:12704363
RGD:5131484
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
NOS2
nitric oxide synthase 2
IEP
protein:increased expression:nasal mucosa
RGD
PMID:18254476
RGD:4891910
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NPY
neuropeptide Y
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
NTRK1
neurotrophic receptor tyrosine kinase 1
IEP
protein:increased expression:eosinophil
RGD
PMID:18647313
RGD:5144116
NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,636...156,881,850
G
OPA1
OPA1 mitochondrial dynamin like GTPase
ISO
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
G
PLAU
plasminogen activator, urokinase
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:21339035
RGD:8547809
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PTGDR2
prostaglandin D2 receptor 2
IEP ISO
RGD
PMID:19230460 PMID:19608418
RGD:5135021 , RGD:5135017
NCBI chr11:60,850,933...60,855,950
Ensembl chr11:60,850,933...60,855,950
G
SCGB3A2
secretoglobin family 3A member 2
IEP
protein:increased expression:sputum mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:17218572 PMID:21385388
RGD:5144232 , RGD:5147389
NCBI chr 5:147,878,711...147,882,191
Ensembl chr 5:147,870,682...147,882,191
G
SERPINE1
serpin family E member 1
susceptibility
IAGP
DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:19063817
RGD:4144832
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SFTPD
surfactant protein D
susceptibility
IAGP
associated with Hypersensitivity;DNA:polymorphism: :p.M11T (human)
RGD
PMID:19493231
RGD:4143494
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
TAP1
transporter 1, ATP binding cassette subfamily B member
susceptibility no_association
IAGP
DNA:SNPs: :
RGD
PMID:17982230 PMID:12018331
RGD:6482262 , RGD:6482274
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
TBXA2R
thromboxane A2 receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
G
TGFB1
transforming growth factor beta 1
IEP
associated with Sinusitis
RGD
PMID:18423831
RGD:4145277
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TLR2
toll like receptor 2
susceptibility no_association
IAGP IEP
DNA:SNPs: :597T>C, 1350T>C (human) mRNA:decreased expression:nasal mucosa: associated with Sinusitis;DNA:SNPs: :multiple (human)
RGD
PMID:19763595 PMID:18219831 PMID:19128592
RGD:4145354 , RGD:7800742 , RGD:4145356
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR6
toll like receptor 6
IAGP
associated with Asthma;DNA:SNP: :rs2381289 (human)
RGD
PMID:20815312
RGD:4145352
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
G
TNF
tumor necrosis factor
IDA ISO
mRNA:increased expression:nose
RGD
PMID:15120189 PMID:20696593
RGD:4143470 , RGD:4145454
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
VEGFA
vascular endothelial growth factor A
IEP
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VIP
vasoactive intestinal peptide
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121 PMID:14680090
NCBI chr 6:152,750,797...152,759,760
Ensembl chr 6:152,750,797...152,759,765
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
IAGP
DNA:haplotype: :
RGD
PMID:17321882
RGD:8547664
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP
DNA:haplotype: :
RGD
PMID:17321882
RGD:8547664
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
ANXA1
annexin A1
IEP
associated with Nasal Polyps
RGD
PMID:22279949
RGD:7421555
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393
G
C3
complement C3
IEP
protein:increased expression:serum
RGD
PMID:19593977
RGD:4889484
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C4A
complement C4A (Chido/Rodgers blood group)
disease_progression
IAGP
DNA:deletion: :
RGD
PMID:16879240
RGD:5688262
NCBI chr 6:31,982,057...32,002,681
Ensembl chr 6:31,982,057...32,002,681
G
CCL20
C-C motif chemokine ligand 20
IEP
RGD
PMID:16702571
RGD:7483585
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
HGF
hepatocyte growth factor
susceptibility
IAGP
DNA:haplotype::rs38850,rs38855,rs38857(human)
RGD
PMID:20416453
RGD:8548615
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
IGF1
insulin like growth factor 1
ISO
mRNA:increased expression:nose:
RGD
PMID:20713758
RGD:8548883
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IL10
interleukin 10
IEP
protein:decreased expression:blood, mononuclear cell
RGD
PMID:23168151
RGD:7364820
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL17A
interleukin 17A
IEP
associated with Asthma;mRNA, protein:increased expression:nasal polyps (human)
RGD
PMID:19672092
RGD:4889146
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1B
interleukin 1 beta
IEP
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112
RGD:7401169
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL22RA1
interleukin 22 receptor subunit alpha 1
susceptibility
IAGP
DNA:SNPs:5' utr, intron: (rs4292900, rs16829225, rs4648936) (human)
RGD
PMID:19393422
RGD:5147411
NCBI chr 1:24,119,771...24,143,140
Ensembl chr 1:24,119,771...24,143,140
G
IL4
interleukin 4
treatment
IEP
associated with Asthma
RGD
PMID:12787306
RGD:7829803
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
MMP9
matrix metallopeptidase 9
IEP
RGD
PMID:23401274
RGD:8547880
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
treatment
ISO
RGD
PMID:23131200 PMID:19389874
RGD:7349403 , RGD:7364734
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
PRKRA
protein activator of interferon induced protein kinase EIF2AK2
severity
IEP
associated with Nasal Polyps
RGD
PMID:22961479
RGD:7777146
NCBI chr 2:178,431,414...178,451,175
Ensembl chr 2:178,431,292...178,451,512
G
SERPINE1
serpin family E member 1
IEP
protein:increased expression:nasal mucosa (human)
RGD
PMID:21711960
RGD:6483796
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
TLR2
toll like receptor 2
susceptibility
IEP IAGP
mRNA,protein:increased expression:paranasal sinus DNA:polymorphisms:: rs3804099,rs3804100(human)
RGD
PMID:22182736 PMID:21493395
RGD:7800733 , RGD:8552975
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
IEP
mRNA,protein:increased expression:paranasal sinus
RGD
PMID:22182736
RGD:7800733
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
IEP ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112 PMID:20147558
RGD:7401169 , RGD:7401236
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
IAGP
DNA:polymorphisms, haplotypes:cds:HLA-DQB1*0301, HLA-DQB1*0302 (human)
RGD
PMID:15577839
RGD:5147654
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
ALOX5
arachidonate 5-lipoxygenase
IEP
RGD
PMID:16677242
RGD:5147463
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
APOA4
apolipoprotein A4
resistance
IEP
protein:increased expression:blood serum (human)
RGD
PMID:20810159
RGD:5685642
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
BDNF
brain derived neurotrophic factor
severity
IEP
protein:increased expression:blood, nasal cavity epithelium
RGD
PMID:18266897
RGD:5144117
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
CCL5
C-C motif chemokine ligand 5
IEP
protein:increased expression:inferior turbinate, epithelium (human)
RGD
PMID:20459697
RGD:4891379
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CMA1
chymase 1
IEP
protein:increased expression:nasal mucosa, mast cell (human)
RGD
PMID:11549546
RGD:5128839
NCBI chr14:24,505,353...24,508,265
Ensembl chr14:24,505,353...24,508,265
G
CST1
cystatin SN
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23950865
NCBI chr20:23,747,562...23,750,935
Ensembl chr20:23,747,562...23,751,268
G
FGA
fibrinogen alpha chain
IDA
RGD
PMID:21887273
RGD:5688767
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
G
GSTO1
glutathione S-transferase omega 1
IEP
protein:decreased expression;T lymphocyte:
RGD
PMID:21410266
RGD:5491008
NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP
DNA:polymorphism:cds:HLA-DQB1*05 (human) DNA:polymorphisms, haplotype:cds:HLA-DQB1*0301, HLA-DQB1*0501 (human)
RGD
PMID:22032123 PMID:9641569
RGD:7421561 , RGD:7421576
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
ICAM1
intercellular adhesion molecule 1
IEP
protein:increased secretion:nasopharynx, secretion (human)
RGD
PMID:20128420
RGD:4145459
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNGR1
interferon gamma receptor 1
IAGP
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
G
IL10
interleukin 10
treatment
IEP
RGD
PMID:19505388
RGD:7365025
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL18
interleukin 18
susceptibility no_association
IAGP
DNA:SNPs:promoters, exon:multiple DNA:SNPs:promoters:multiple
RGD
PMID:12532106 PMID:12532106
RGD:8655871 , RGD:8655871
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL4
interleukin 4
IEP
protein:increased expression:serum mRNA:increased expression:nose:
RGD
PMID:9237816 PMID:7551298
RGD:7829817 , RGD:8662960
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
KDR
kinase insert domain receptor
IEP
protein:increased expression:nasal cavity of mucosa:
RGD
PMID:17651148
RGD:8551771
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
MC1R
melanocortin 1 receptor
no_association
ISO
RGD
PMID:20357480
RGD:5687317
NCBI chr16:89,918,862...89,920,972
Ensembl chr16:89,912,119...89,920,973
G
MMP9
matrix metallopeptidase 9
IAGP
DNA:SNPs:promoter, intron, cds:-1590C>T, 2127G>T, p.R668Q (rs3918242, rs2274755, rs17577) (human)
RGD
PMID:22237587
RGD:8547819
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
NOD1
nucleotide binding oligomerization domain containing 1
susceptibility
IAGP
DNA:SNP: :rs2075817 (human)
RGD
PMID:16918516
RGD:5131519
NCBI chr 7:30,424,527...30,478,784
Ensembl chr 7:30,424,527...30,478,784
G
NOD2
nucleotide binding oligomerization domain containing 2
susceptibility
IAGP
DNA:polymorphisms:5'UTR/exon, exon:rs5743266, rs2066842 (human)
RGD
PMID:16008671
RGD:5131477
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
PTGS1
prostaglandin-endoperoxide synthase 1
IEP
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
SCGB1A1
secretoglobin family 1A member 1
IEP
mRNA, protein:decreased expression:nasal lavage fluid
RGD
PMID:15836756
RGD:5144234
NCBI chr11:62,419,033...62,423,195
Ensembl chr11:62,405,103...62,423,195
G
TLR3
toll like receptor 3
IEP
protein:decreased expression:bone marrow, blood, eosinophil (human)
RGD
PMID:19752565
RGD:5129130
NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073
G
TLR4
toll like receptor 4
susceptibility
IAGP
DNA:polymorphisms:cds:p.D299G, T399I (human)
RGD
PMID:18517079
RGD:4144192
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
VEGFA
vascular endothelial growth factor A
IEP
mRNA,protein:increased expression:nasal biopsies,nasal lavage fluid:
RGD
PMID:12633568
RGD:7483595
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
susceptibility
IAGP
RGD
PMID:15784866
RGD:5128832
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
G
ACE
angiotensin I converting enzyme
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15381116
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACE2
angiotensin converting enzyme 2
treatment susceptibility severity
EXP ISO IMP
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:heart (mouse) human gene in a mouse model
CTD RGD
PMID:14647384 PMID:16007097 PMID:16166518 PMID:16339146 PMID:19453650 PMID:19625462 PMID:23678171 PMID:24172901 PMID:24227843 PMID:26801988 PMID:31996437 PMID:32092392 PMID:32201080 PMID:19453650 PMID:32553273 PMID:17974127 PMID:16007097 More...
RGD:40818405 , RGD:32716426 , RGD:30309965 , RGD:30309202
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ANPEP
alanyl aminopeptidase, membrane
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401
G
BPI
bactericidal permeability increasing protein
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr20:38,304,156...38,337,505
Ensembl chr20:38,304,150...38,337,505
G
C1QB
complement C1q B chain
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637
G
C5AR1
complement C5a receptor 1
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr19:47,307,477...47,322,066
Ensembl chr19:47,290,023...47,322,066
G
CASP3
caspase 3
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP9
caspase 9
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CCL1
C-C motif chemokine ligand 1
ISO
mRNA: increased expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
G
CCL2
C-C motif chemokine ligand 2
treatment severity
EXP IEP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:bronchoalveolar lavage (human) protein:increased expression:serum (human) mRNA, protein: increased expression, altered expression:lung (mouse) protein:increased expression:plasma (human)
CTD RGD
PMID:20484496 PMID:15888207 PMID:32553273 PMID:15602737 PMID:15356152 PMID:15781938 PMID:15657466 PMID:16195357 More...
RGD:34201108 , RGD:32716426 , RGD:32716399 , RGD:30309221 , RGD:30309220 , RGD:30309219 , RGD:30309218
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL3
C-C motif chemokine ligand 3
ISO
mRNA, protein: increased expression, altered expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL5
C-C motif chemokine ligand 5
severity treatment
IAGP IEP ISO
Severe Acute Respiratory Syndrome; DNA:transversion:5' utr:-28C>G (human) protein:increased expression:bronchoalveolar lavage (human) mRNA, protein: increased expression, altered expression:lung, brain (mouse) protein:increased expression:plasma (human) mRNA:increased expression:lung (mouse)
RGD
PMID:19258635 PMID:15888207 PMID:15865221 PMID:32553273 PMID:15356152 PMID:15781938 PMID:16195357 PMID:32365944 More...
RGD:4891448 , RGD:34201108 , RGD:33769580 , RGD:32716426 , RGD:30309221 , RGD:30309220 , RGD:30309218 , RGD:30309207
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCR1
C-C motif chemokine receptor 1
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CCR3
C-C motif chemokine receptor 3
ISO
mRNA:altered expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CD14
CD14 molecule
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD3E
CD3 epsilon subunit of T-cell receptor complex
IEP
protein:increased expression:Tcell, testis (human)
RGD
PMID:16237152
RGD:27372876
NCBI chr11:118,304,730...118,316,173
Ensembl chr11:118,304,730...118,316,175
G
CD4
CD4 molecule
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr12:6,789,528...6,820,799
Ensembl chr12:6,786,858...6,820,799
G
CD68
CD68 molecule
disease_progression
IEP
mRNA, protein:increased expression:lung (human) protein:increased expression:macrophage, testis (human)
RGD
PMID:19635508 PMID:16237152
RGD:5490168 , RGD:27372876
NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
G
CD9
CD9 molecule
disease_progression
IEP
mRNA, protein:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
G
CEACAM8
CEA cell adhesion molecule 8
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr19:42,580,243...42,594,924
Ensembl chr19:42,580,243...42,595,055
G
CLCF1
cardiotrophin like cytokine factor 1
disease_progression
IEP
mRNA:decreased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr11:67,364,168...67,374,177
Ensembl chr11:67,364,168...67,374,177
G
CLEC4M
C-type lectin domain family 4 member M
susceptibility no_association
IAGP
DNA:repeats:exon 4:
RGD
PMID:16369534 PMID:18708672 PMID:17534355 PMID:17534354
RGD:35673327 , RGD:36049808 , RGD:36049807 , RGD:36049806
NCBI chr19:7,763,243...7,769,605
Ensembl chr19:7,763,210...7,769,605
G
CTSL
cathepsin L
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16081529 PMID:16339146 PMID:22496216 PMID:23678171
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19741068
RGD:4143520
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
treatment severity disease_progression
IEP ISO
protein:increased expression:serum protein:increased expression:serum (human) mRNA, protein: increased expression, altered expression:lung (mouse) mRNA, protein:increased expression:serum, lung (human) mRNA, protein:increased expression:plasma, lung (human) protein:increased expression:lung (human) protein:increased expression:lung (mouse) mRNA:increased expression:lung (mouse) mRNA:decreased expression:lung (human)
RGD
PMID:17052299 PMID:15865221 PMID:32553273 PMID:15602737 PMID:15356152 PMID:15781938 PMID:15657466 PMID:16195357 PMID:17129463 PMID:20231782 PMID:32365944 PMID:19635508 More...
RGD:5135440 , RGD:33769580 , RGD:32716426 , RGD:32716399 , RGD:30309221 , RGD:30309220 , RGD:30309219 , RGD:30309218 , RGD:30309217 , RGD:30309216 , RGD:30309207 , RGD:5490168
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL11
C-X-C motif chemokine ligand 11
treatment
ISO
RGD
PMID:32553273
RGD:32716426
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
G
CXCL5
C-X-C motif chemokine ligand 5
ISO
protein:increased expression:respiratory fluid/secretion
RGD
PMID:19741068
RGD:4143520
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
protein:increased expression:respiratory fluid/secretion mRNA:decreased expression:lung (mouse)
RGD
PMID:19741068 PMID:32364527
RGD:27226699 RGD:4143520
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCL8
C-X-C motif chemokine ligand 8
disease_progression treatment severity
IEP
mRNA:increased expression:lung (human) protein:increased expression:serum (human) protein:increased expression:blood (human) protein:increased expression:bronchoalveolar lavage (human) protein:increased expression:plasma (human)
RGD
PMID:19635508 PMID:15271897 PMID:15472864 PMID:15888207 PMID:15865221 PMID:14514395 PMID:15657466 PMID:16195357 More...
RGD:5490168 , RGD:32716401 , RGD:34888224 , RGD:34201108 , RGD:33769580 , RGD:30309961 , RGD:30309219 , RGD:30309218
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCL9
C-X-C motif chemokine ligand 9
severity treatment
ISO IEP
mRNA, protein:increased expression:lung protein:increased expression:bronchoalveolar lavage (human) protein:increased expression:plasma (human) protein:increased expression:serum (human) mRNA, protein: increased expression, altered expression:lung (mouse)
RGD
PMID:19906920 PMID:15888207 PMID:16195357 PMID:15602737 PMID:15356152 PMID:15781938 More...
RGD:4891446 , RGD:34201108 , RGD:30309218 , RGD:32716399 , RGD:30309221 , RGD:30309220
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
mRNA:altered expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
EGFR
epidermal growth factor receptor
severity
ISO
RGD
PMID:28404843
RGD:38599178
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
FGB
fibrinogen beta chain
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
G
FGF7
fibroblast growth factor 7
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr15:49,423,242...49,488,775
Ensembl chr15:49,423,237...49,488,775
G
FGG
fibrinogen gamma chain
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 4:154,604,136...154,612,656
Ensembl chr 4:154,604,134...154,612,967
G
FN1
fibronectin 1
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
FSHB
follicle stimulating hormone subunit beta
IEP
protein:increased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
G
GH1
growth hormone 1
IEP
protein:decreased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
G
HLA-B
major histocompatibility complex, class I, B
severity
IAGP
DNA:polymorphism:cds:HLA-B*0703 (human) DNA:polymorphism:cds:HLA-B*4601 (human)
RGD
PMID:15243926 PMID:12969506
RGD:32716381 , RGD:32716382
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-DRA
major histocompatibility complex, class II, DR alpha
disease_progression
IEP
mRNA:increased expression:lung
RGD
PMID:19635508
RGD:5490168
NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
IAGP
DNA:polymorphism:cds:HLA-DRB1*12 (human) DNA:polymorphism:cds:HLA-DRB1*0301 (human)
RGD
PMID:19445991 PMID:15243926
RGD:32716374 , RGD:32716381
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HP
haptoglobin
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
IFNA1
interferon alpha 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:15200845
NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316
G
IFNB1
interferon beta 1
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15200845 PMID:26861016 PMID:32553273
RGD:32716426
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
G
IFNG
interferon gamma
susceptibility treatment
IAGP IEP
DNA:polymorphism:cds:+874A>T(human) protein:increased expression:peripheral blood mononuclear cells (human) protein:increased expression:serum (human) DNA:SNP:intron:+874A>T (rs2430561)(human)
RGD
PMID:19258635 PMID:15865221 PMID:16781892 PMID:15602737 PMID:16672072 PMID:19526193 PMID:17872527 More...
RGD:4891448 , RGD:33769580 , RGD:32716400 , RGD:32716399 , RGD:32716398 , RGD:32716397 , RGD:32716396
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGF1
insulin like growth factor 1
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IL10
interleukin 10
treatment
ISO IEP
protein:increased expression:serum, bronchoalveolar Lavage fluid (rat)
RGD
PMID:16409721 PMID:15865221
RGD:32726073 , RGD:33769580
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL18
interleukin 18
IEP
protein:increased expression:serum (human)
RGD
PMID:15602737
RGD:32716399
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
ISO
mRNA:altered expression:lung (mouse)
RGD
PMID:32364527
RGD:27226699
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
severity
ISO
mRNA:altered expression:lung (mouse) mRNA, protein:increased expression:lung, bronchoalveolar lavage (mouse)
RGD
PMID:32364527 PMID:32365944
RGD:27226699 , RGD:30309207
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1R1
interleukin 1 receptor type 1
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
G
IL23A
interleukin 23 subunit alpha
ISO
mRNA:decreased expression:lung (mouse)
RGD
PMID:32364527
RGD:27226699
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
G
IL6
interleukin 6
severity disease_progression treatment
IEP ISO
protein:increased expression:serum (human) protein:increased expression:blood (human) protein:increased expression:bronchoalveolar lavage (human) protein:increased expression:serum, Bronchoalveolar Lavage fluid (rat)
RGD
PMID:15657466 PMID:15472864 PMID:15888207 PMID:15865221 PMID:16409721 PMID:32553273 PMID:15271897 More...
RGD:30309219 , RGD:34888224 , RGD:34201108 , RGD:33769580 , RGD:32726073 , RGD:32716426 , RGD:32716401
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL7
interleukin 7
ISO
mRNA:decreased expression:lung (mouse)
RGD
PMID:32364527
RGD:27226699
NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523
G
IRF3
interferon regulatory factor 3
disease_progression
EXP IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung (human)
CTD RGD
PMID:26861016 PMID:19635508
RGD:5490168
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
G
ITGA2B
integrin subunit alpha 2b
disease_progression
IEP
mRNA:decreased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr17:44,372,181...44,389,649
Ensembl chr17:44,372,180...44,389,649
G
KRT7
keratin 7
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
G
LHB
luteinizing hormone subunit beta
IEP
protein:increased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
G
MAPK1
mitogen-activated protein kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20484496
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20484496
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MSR1
macrophage scavenger receptor 1
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 8:16,107,881...16,192,651
Ensembl chr 8:16,107,878...16,567,490
G
MYD88
MYD88 innate immune signal transduction adaptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
G
NFIL3
nuclear factor, interleukin 3 regulated
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832
G
NLRP3
NLR family pyrin domain containing 3
ISO
RGD
PMID:32365944
RGD:30309207
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
G
PECAM1
platelet and endothelial cell adhesion molecule 1
disease_progression
IEP
mRNA, protein:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PI4KB
phosphatidylinositol 4-kinase beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253445
NCBI chr 1:151,291,797...151,327,715
Ensembl chr 1:151,291,797...151,327,715
G
PLAT
plasminogen activator, tissue type
IEP
protein:increased expression:plasma (human)
RGD
PMID:16274108
RGD:30309949
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
PLG
plasminogen
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 6:160,702,193...160,754,097
Ensembl chr 6:160,702,194...160,754,097
G
POMC
proopiomelanocortin
IEP
protein:decreased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
PRL
prolactin
IEP
protein:increased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
RAB31
RAB31, member RAS oncogene family
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr18:9,708,301...9,862,551
Ensembl chr18:9,708,275...9,862,551
G
RELA
RELA proto-oncogene, NF-kB subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
S100A8
S100 calcium binding protein A8
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
G
SERPINA3
serpin family A member 3
IEP
protein:increased expression:plasma
RGD
PMID:16649161
RGD:5147434
NCBI chr14:94,612,391...94,624,053
Ensembl chr14:94,612,384...94,624,055
G
SLPI
secretory leukocyte peptidase inhibitor
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
STAT1
signal transducer and activator of transcription 1
ISS
MouseDO
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
TBK1
TANK binding kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr12:64,452,120...64,502,114
Ensembl chr12:64,452,090...64,502,114
G
TGFB1
transforming growth factor beta 1
IEP ISO
protein:increased expression:serum (human) protein:increased expression:serum, bronchoalveolar Lavage fluid (rat)
RGD
PMID:15271897 PMID:16409721
RGD:32716401 , RGD:32726073
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
THBD
thrombomodulin
IEP
protein:increased expression:plasma (human)
RGD
PMID:16274108
RGD:30309949
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
TICAM2
TIR domain containing adaptor molecule 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr 5:115,578,496...115,602,479
Ensembl chr 5:115,578,496...115,602,479
G
TIRAP
TIR domain containing adaptor protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr11:126,283,093...126,294,933
Ensembl chr11:126,282,497...126,298,845
G
TLR2
toll like receptor 2
disease_progression
IEP
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TMPRSS11D
transmembrane serine protease 11D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24227843
NCBI chr 4:67,820,876...67,884,002
Ensembl chr 4:67,820,876...67,884,002
G
TMPRSS2
transmembrane serine protease 2
severity
ISO
RGD
PMID:30626688
RGD:30309210
NCBI chr21:41,529,791...41,531,118
Ensembl chr21:41,464,300...41,531,116
G
TMPRSS2
transmembrane serine protease 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22496216 PMID:24227843 PMID:30626688
NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
G
TNF
tumor necrosis factor
IEP
protein:increased expression:plasma (human) protein:increased expression:bronchoalveolar lavage (human)
RGD
PMID:14514395 PMID:15888207
RGD:30309961 , RGD:34201108
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TSHB
thyroid stimulating hormone subunit beta
IEP
protein:decreased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr 1:115,029,826...115,034,309
Ensembl chr 1:115,029,826...115,034,302
G
VIM
vimentin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26801988
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
VWF
von Willebrand factor
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
G
XCL1
X-C motif chemokine ligand 1
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr 1:168,576,605...168,582,069
Ensembl chr 1:168,576,605...168,582,069
G
STING1
stimulator of interferon response cGAMP interactor 1
severity
ISO
RGD
PMID:31141689
RGD:39128194
NCBI chr 5:139,475,533...139,482,758
Ensembl chr 5:139,475,533...139,482,935
G
AZGP1
alpha-2-glycoprotein 1, zinc-binding
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 7:99,966,730...99,976,031
Ensembl chr 7:99,966,720...99,976,042
G
CCL4
C-C motif chemokine ligand 4
IEP
RGD
PMID:19786211
RGD:5130914
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CFB
complement factor B
IEP
protein:decreased expression:serum
RGD
PMID:14510109
RGD:7411729
NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,086
G
CFTR
CF transmembrane conductance regulator
susceptibility
IAGP EXP
DNA:mutations: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16083808 PMID:11773581
RGD:4140477
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CHIA
chitinase acidic
severity
IEP
mRNA:decreased expression:sinus, epithelial cell (human)
RGD
PMID:19379605
RGD:5037227
NCBI chr 1:111,290,851...111,320,563
Ensembl chr 1:111,290,851...111,320,566
G
CXCL5
C-X-C motif chemokine ligand 5
IEP
associated with Rhinitis;mRNA:increased expression:paranasal sinus
RGD
PMID:19153309
RGD:5135257
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
IL13
interleukin 13
susceptibility
IAGP EXP
associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20358028 PMID:20358028
RGD:4145767
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL1B
interleukin 1 beta
IEP
associated with Hypersensitivity
RGD
PMID:16358839
RGD:4143214
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL2
interleukin 2
IEP
RGD
PMID:11758471
RGD:8662964
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
LTA
lymphotoxin alpha
susceptibility
IAGP
DNA:polymorphism: :
RGD
PMID:11037831
RGD:4143260
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
G
MET
MET proto-oncogene, receptor tyrosine kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
G
MMP9
matrix metallopeptidase 9
IEP
protein:increased expression: :
RGD
PMID:20392482
RGD:5130763
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
IEP
protein:increased secretion:sinus mucus
RGD
PMID:17063754
RGD:5131192
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
G
NR3C1
nuclear receptor subfamily 3 group C member 1
IEP
RGD
PMID:18396779
RGD:4892328
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
PDGFB
platelet derived growth factor subunit B
IEP
protein: increased expression: nasal cavity epithelium
RGD
PMID:21255638
RGD:6483060
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PIP
prolactin induced protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 7:143,132,077...143,139,739
Ensembl chr 7:143,132,077...143,139,739
G
PLAU
plasminogen activator, urokinase
IEP
RGD
PMID:21711960
RGD:6483796
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PLAUR
plasminogen activator, urokinase receptor
IEP
RGD
PMID:21711960
RGD:6483796
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PPP1R9B
protein phosphatase 1 regulatory subunit 9B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr17:50,133,737...50,150,677
Ensembl chr17:50,133,737...50,150,677
G
SCGB3A2
secretoglobin family 3A member 2
IEP
mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:21385388
RGD:5147389
NCBI chr 5:147,878,711...147,882,191
Ensembl chr 5:147,870,682...147,882,191
G
SFTPA1
surfactant protein A1
IEP
associated with Cystic Fibrosis;mRNA:increased expression:respiratory system mucosa
RGD
PMID:17599561
RGD:4143506
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SFTPD
surfactant protein D
IEP
associated with Cystic Fibrosis;mRNA:increased expression:respiratory system mucosa
RGD
PMID:17599561
RGD:4143506
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
TLR2
toll like receptor 2
IEP
mRNA:increased expression:nasal cavity epithelium:
RGD
PMID:14743629
RGD:8552991
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
ISO IEP
associated with Pneumococal Infections; mRNA:increased expression:nasal cavity epithelium:
RGD
PMID:16301373 PMID:14743629
RGD:7800729 , RGD:8552991
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR9
toll like receptor 9
IEP
Acute Sinusitis; protein:decreased expression:nasal mucosa, epithelial cell (human) Chronic Sinusitis; protein:decreased expression:nasal mucosa, epithelial cell (human)
RGD
PMID:18416964 PMID:17283572
RGD:5130708 , RGD:5130870
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:23613163
RGD:38676477
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
CD86
CD86 molecule
ISO
protein:decreased expression:spleen, plasmacytoid dendritic cell (mouse)
RGD
PMID:20949109
RGD:4892562
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CFTR
CF transmembrane conductance regulator
ISO
RGD
PMID:28289144
RGD:36049750
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CSF3
colony stimulating factor 3
treatment
IDA
RGD
PMID:10228098
RGD:11039478
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
FN1
fibronectin 1
ISO
RGD
PMID:12065530
RGD:7205474
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
IFNAR1
interferon alpha and beta receptor subunit 1
susceptibility
ISO
RGD
PMID:19603548 PMID:19603548
RGD:5490273 , RGD:5490273
NCBI chr21:33,324,395...33,359,864
Ensembl chr21:33,324,387...33,359,864
G
IL10
interleukin 10
ISO
mRNA, protein:increased expression:lung
RGD
PMID:22940620
RGD:7364825
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL15
interleukin 15
ISO
RGD
PMID:18390740
RGD:4996474
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL1B
interleukin 1 beta
ISO
RGD
PMID:20065029
RGD:4142828
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL33
interleukin 33
ISO
mRNA:increased expression:lung:
RGD
PMID:28401938
RGD:40400699
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
RGD
PMID:20493961
RGD:5131444
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:lung (mouse)
RGD
PMID:28663335
RGD:13432209
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
G
PTPN11
protein tyrosine phosphatase non-receptor type 11
severity
ISO
mRNA:increased expression:lung associated with influenza
RGD
PMID:31782850 PMID:31782850
RGD:39131288 , RGD:39131288
NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
G
RIPK3
receptor interacting serine/threonine kinase 3
treatment
ISO
RGD
PMID:25445964
RGD:127229910
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
G
SFTPB
surfactant protein B
ameliorates
IDA
RGD
PMID:20007532
RGD:151667448
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
G
ATM
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:27421701
RGD:126779562
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102
G
BTK
Bruton tyrosine kinase
ISO
RGD
PMID:30873567
RGD:124715473
NCBI chr X:101,349,450...101,390,796
Ensembl chr X:101,349,338...101,390,796
G
CLEC4M
C-type lectin domain family 4 member M
severity
ISO
RGD
PMID:16134084
RGD:39938986
NCBI chr19:7,763,243...7,769,605
Ensembl chr19:7,763,210...7,769,605
G
IDO1
indoleamine 2,3-dioxygenase 1
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:20385761
RGD:39938865
NCBI chr 8:39,913,891...39,928,790
Ensembl chr 8:39,902,275...39,928,790
G
IFNG
interferon gamma
ISO
protein:increased expression:lung,natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL6
interleukin 6
ISO
protein:increased expression:lung,natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRAK3
interleukin 1 receptor associated kinase 3
severity
ISO
RGD
PMID:22492852
RGD:35316076
NCBI chr12:66,189,214...66,254,622
Ensembl chr12:66,189,195...66,254,622
G
ITGB2
integrin subunit beta 2
susceptibility
ISO
RGD
PMID:11390487
RGD:127345090
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
G
LAMP1
lysosomal associated membrane protein 1
ISO
protein:increased expression:lung, natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672
G
MARCO
macrophage receptor with collagenous structure
exacerbates
ISO
RGD
PMID:15263032
RGD:41412189
NCBI chr 2:118,942,194...118,994,660
Ensembl chr 2:118,942,194...118,994,660
G
NCR1
natural cytotoxicity triggering receptor 1
severity
ISO
RGD
PMID:21887255
RGD:40818252
NCBI chr19:54,898,198...54,938,208
Ensembl chr19:54,906,148...54,916,140
G
PDCD1
programmed cell death 1
treatment
ISO
RGD
PMID:25624454
RGD:40818422
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
treatment
ISO
associated with immunodeficiency 14
RGD
PMID:30093657
RGD:40890269
NCBI chr 1:9,627,258...9,729,114
Ensembl chr 1:9,629,889...9,729,114
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
severity
ISO
RGD
PMID:17322108
RGD:38599154
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
G
RIPK3
receptor interacting serine/threonine kinase 3
exacerbates
ISO
RGD
PMID:33625952
RGD:127229925
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
G
TNF
tumor necrosis factor
ISO
protein:increased expression:lung,natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
IL18
interleukin 18
treatment
ISO
RGD
PMID:16129701
RGD:8655932
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL5
interleukin 5
severity
ISO
RGD
PMID:9824515
RGD:11354934
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
IGFBP3
insulin like growth factor binding protein 3
treatment
IEP
RGD
PMID:27738609
RGD:12743605
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
ADAM33
ADAM metallopeptidase domain 33
susceptibility
IAGP
DNA:SNP: :rs2787094 c.2891G>C (human)
RGD
PMID:19258923
RGD:4142862
NCBI chr20:3,667,975...3,682,010
Ensembl chr20:3,667,965...3,682,246
G
BCL2
BCL2 apoptosis regulator
severity
IEP
protein:increased expression:natural killer cell, T cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
severity
IEP
protein:increased expression:natural killer cell,t cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
C3
complement C3
resistance
IAGP ISO
RGD
PMID:19258923 PMID:12235218
RGD:4142862 , RGD:5129513
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CASP1
caspase 1
IEP
RGD
PMID:15196254
RGD:5130189
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CAT
catalase
IEP
protein:decreased expression:nasal mucus
RGD
PMID:21471094
RGD:5130770
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL5
C-C motif chemokine ligand 5
susceptibility
IEP IAGP
protein:increased secretion:serum (human) DNA:snp:5' utr:g.-28C>G (human)
RGD
PMID:19005677 PMID:19099677
RGD:4891884 , RGD:4891881
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CD14
CD14 molecule
IAGP
DNA:polymorphism:promoter:c.-550C>T (human)
RGD
PMID:17471431
RGD:4144210
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD274
CD274 molecule
treatment
ISO
mRNA:increased expression:lung
RGD
PMID:22797302 PMID:22797302
RGD:40818270 , RGD:40818270
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
CSF2
colony stimulating factor 2
IEP
protein:increased expression:nasal mucus
RGD
PMID:20088864
RGD:4143440
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CX3CR1
C-X3-C motif chemokine receptor 1
IEP IAGP
DNA:SNP: :p.T280M (human)
RGD
PMID:18257903 PMID:16645504
RGD:4891891 , RGD:4891905
NCBI chr 3:39,263,494...39,292,966
Ensembl chr 3:39,263,495...39,281,735
G
CXCL10
C-X-C motif chemokine ligand 10
ISO IEP
mRNA:increased expression:lung protein:increased expression:plasma
RGD
PMID:12909590 PMID:20561238
RGD:2311388 , RGD:5135493
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCR3
C-X-C motif chemokine receptor 3
IEP
RGD
PMID:20561238
RGD:5135493
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
FAS
Fas cell surface death receptor
severity
HEP
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FLT3
fms related receptor tyrosine kinase 3
severity
HEP
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
severity
HEP
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
G
IFNL1
interferon lambda 1
exacerbates
IEP
associated with respiratory syncytial virus infectious disease;mRNA:increased expression:mucosa of nasopharynx (human)
RGD
PMID:24389019
RGD:126848743
NCBI chr19:39,296,407...39,298,673
Ensembl chr19:39,296,407...39,298,673
G
IL15
interleukin 15
severity
IEP
mRNA,protein:increased expression:peripheral blood mononuclear cell,serum,dendritic cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL17A
interleukin 17A
susceptibility
IAGP
DNA:SNP: :rs7747909(human)
RGD
PMID:17703412
RGD:4889847
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1RN
interleukin 1 receptor antagonist
susceptibility
IAGP
DNA:SNP: :c.390T>C (rs315952) (human)
RGD
PMID:19258923
RGD:4142862
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL33
interleukin 33
IEP
protein:increased expression:nasal mucus
RGD
PMID:28471975
RGD:38596342
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
IL4R
interleukin 4 receptor
susceptibility
ISO IAGP
DNA:SNPs: :rs1805011,rs2057768 (human) associated with respiratory syncystial virus infection; DNA:polymorphism:cds:p. Q551R (human)
RGD
PMID:20404812 PMID:17703412 PMID:12508140
RGD:4889996 , RGD:4889847 , RGD:4890022
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
IEP
mRNA, protein:increased expression:respiratory system fluid/secretion
RGD
PMID:14738241
RGD:5128668
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL9
interleukin 9
IEP
RGD
PMID:15051283
RGD:5128692
NCBI chr 5:135,892,246...135,895,841
Ensembl chr 5:135,892,246...135,895,841
G
JAK3
Janus kinase 3
severity
HEP
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071
G
KLRK1
killer cell lectin like receptor K1
susceptibility
IAGP
DNA:SNP,haplotypes:3'utr: (rs10772271) (human)
RGD
PMID:29967528
RGD:39128159
NCBI chr12:10,372,353...10,390,041
Ensembl chr12:10,372,353...10,391,874
G
MPO
myeloperoxidase
IEP
RGD
PMID:7841728
RGD:5130995
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MUC1
mucin 1, cell surface associated
severity
IEP
protein:increased expression:serum
RGD
PMID:19856476
RGD:5131164
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
NFKB1
nuclear factor kappa B subunit 1
severity
HEP
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKBIA
NFKB inhibitor alpha
susceptibility
IAGP
associated with respiratory syncytial virus infectious disease;DNA:SNP:promoter: (rs2233406) (human)
RGD
PMID:23487427
RGD:40902982
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NOS2
nitric oxide synthase 2
susceptibility
IAGP
DNA:SNP: :rs1060826(human)
RGD
PMID:17703412
RGD:4889847
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PDCD1
programmed cell death 1
ISO
protein:increased expression:CD8 T cell
RGD
PMID:22797302
RGD:40818270
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
POSTN
periostin
IEP
mRNA,protein:increased expression:nasal mucus
RGD
PMID:28471975
RGD:38596342
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
G
STAT5A
signal transducer and activator of transcription 5A
severity
HEP
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr17:42,287,439...42,311,943
Ensembl chr17:42,287,547...42,311,943
G
TLR4
toll like receptor 4
IEP
protein:decreased expression:neutrophil protein:increased expression:monocyte
RGD
PMID:19497921 PMID:14738455
RGD:4144183 , RGD:4144819
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR5
toll like receptor 5
susceptibility
IAGP
DNA:snp:cds:p.F616L rs5744174 (human)
RGD
PMID:19258923
RGD:4142862
NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,248
G
TNF
tumor necrosis factor
susceptibility
IAGP IEP
DNA:SNP: :rs1799724(human) protein:increased expression:nasal lavage fluid DNA:polymorphism:promoter: c. -308A>G (human)
RGD
PMID:17703412 PMID:20088864 PMID:19849941
RGD:4889847 , RGD:4143440 , RGD:4143441
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF10A
TNF receptor superfamily member 10a
severity
HEP
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
G
TSLP
thymic stromal lymphopoietin
severity
IEP
mRNA, protein:increased expression:nasal mucus (human)
RGD
PMID:28471975
RGD:38596342
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
G
VDR
vitamin D receptor
susceptibility
IAGP
DNA:SNP: :rs10735810 (human) DNA:SNP (human)
RGD
PMID:17703412 PMID:18266602
RGD:4889847 , RGD:4889843
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
ACE
angiotensin I converting enzyme
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15381116
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
CCL11
C-C motif chemokine ligand 11
IEP
RGD
PMID:20644177
RGD:4140459
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL2
C-C motif chemokine ligand 2
ISO
RGD
PMID:19617401
RGD:4891451
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL3
C-C motif chemokine ligand 3
HEP
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL4
C-C motif chemokine ligand 4
IEP HEP
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:20957032 PMID:32407669
RGD:5130904 , RGD:30296672
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:15254170
RGD:5688163
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CD68
CD68 molecule
ISO
mRNA:increased expression:lung,trachea (mouse)
RGD
PMID:12581500
RGD:40925942
NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19671179
RGD:5134975
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
RGD
PMID:17655904
RGD:5135437
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL16
C-X-C motif chemokine ligand 16
HEP
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr17:4,733,533...4,739,928
Ensembl chr17:4,733,533...4,739,928
G
CXCL2
C-X-C motif chemokine ligand 2
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19671179
RGD:5134975
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL8
C-X-C motif chemokine ligand 8
HEP
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
RGD
PMID:17655904
RGD:5135437
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
FGF10
fibroblast growth factor 10
treatment
ISO
protein:increased expression:epithelial stem/progenitor cells (mouse)
RGD
PMID:27322618 PMID:27322618
RGD:127284849 , RGD:127284849
NCBI chr 5:44,300,247...44,389,420
Ensembl chr 5:44,300,247...44,389,706
G
FGFR2
fibroblast growth factor receptor 2
ISO
protein:increased expression:epithelial stem/progenitor cells (mouse)
RGD
PMID:27322618
RGD:127284849
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
G
HMOX1
heme oxygenase 1
ISO
mRNA:increased expression:lung
RGD
PMID:8843786
RGD:4145417
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
IFNAR1
interferon alpha and beta receptor subunit 1
disease_progression
ISO
H1N1 virus susceptibility
RGD
PMID:21383977 PMID:21383977
RGD:5490272 , RGD:5490272
NCBI chr21:33,324,395...33,359,864
Ensembl chr21:33,324,387...33,359,864
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:25219125
RGD:10450576
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL15
interleukin 15
ISO
RGD
PMID:20335267
RGD:4892670
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL17RA
interleukin 17 receptor A
HEP
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr22:17,085,000...17,115,693
Ensembl chr22:17,084,954...17,115,693
G
IL1B
interleukin 1 beta
HEP
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
HEP
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL4R
interleukin 4 receptor
HEP
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
MIF
macrophage migration inhibitory factor
ISO
RGD
PMID:19941385
RGD:4891005
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
TLR9
toll like receptor 9
IAGP
DNA:SNP:promoter:g.-1237T>C rs5743836 (human)
RGD
PMID:19539691
RGD:5130766
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:25219125
RGD:10450576
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
RPGR
retinitis pigmentosa GTPase regulator
IAGP EXP
ClinVar Annotator: match by term: Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: RETINITIS PIGMENTOSA, SINORESPIRATORY INFECTIONS, AND DEAFNESS
ClinVar CTD OMIM
PMID:1733835 PMID:8673101 PMID:10094550 PMID:14627685 PMID:16055928 PMID:25741868 More...
NCBI chr X:38,269,163...38,327,509
Ensembl chr X:38,269,163...38,327,544
G
PGK1
phosphoglycerate kinase 1
IAGP
ClinVar Annotator: match by term: Male infertility due to obstructive azoospermia
ClinVar
NCBI chr X:78,104,248...78,129,295
Ensembl chr X:77,910,739...78,129,295
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all